Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in J Acquir Immune Defic Syndr

Retrieve available abstracts of 370 articles:
HTML format
Text format



Single Articles


    December 2018

  1. HIV-1 Proviral Sequence and Treatment Outcome of Virologically Suppressed Patients Switching to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate: Erratum.
    J Acquir Immune Defic Syndr. 2018;79:e111.
    PubMed     Text format    


  2. AMMASSARI A, Stohr W, Antinori A, Molina JM, et al
    Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.
    J Acquir Immune Defic Syndr. 2018;79:481-490.
    PubMed     Text format     Abstract available


  3. MWINNYAA G, Gray RH, Grabowski MK, Ssekasanvu J, et al
    Brief Report: Age-Disparate Relationships and HIV Prevalence Among Never Married Women in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2018;79:430-434.
    PubMed     Text format     Abstract available


  4. OCTAVIANA F, Safri AY, Setiawan DD, Estiasari R, et al
    Detectable Plasma HIV RNA Is Associated With Sensory Neuropathy in Patients With HIV Treated Without Stavudine.
    J Acquir Immune Defic Syndr. 2018;79:e108-e110.
    PubMed     Text format    


  5. GOMES-NETO M, Rodriguez I, Ledo AP, Vieira JPB, et al
    Muscle Strength and Aerobic Capacity in HIV-Infected Patients: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2018;79:491-500.
    PubMed     Text format     Abstract available


  6. THOMA BC, Huebner DM
    Brief Report: HIV Pre-exposure Prophylaxis Engagement Among Adolescent Men Who Have Sex With Men: The Role of Parent-Adolescent Communication About Sex.
    J Acquir Immune Defic Syndr. 2018;79:453-457.
    PubMed     Text format     Abstract available


    November 2018
  7. VENTER WDF, Kambugu A, Chersich MF, Becker S, et al
    Efficacy and safety of tenofovir disoproxil fumarate versus low-dose stavudine over 96 weeks: a multi-country randomised, non-inferiority trial.
    J Acquir Immune Defic Syndr. 2018 Nov 12. doi: 10.1097/QAI.0000000000001908.
    PubMed     Text format     Abstract available


  8. ARPADI S, Lamb M, Isaie Nzeyimana N, Vandebriel G, et al
    Better outcomes among HIV-infected Rwandan children 18-60 months following the implementation of "treat all".
    J Acquir Immune Defic Syndr. 2018 Nov 12. doi: 10.1097/QAI.0000000000001907.
    PubMed     Text format     Abstract available


  9. WELD ED, Rana MS, Dallas RH, Camacho-Gonzalez AF, et al
    Interest of Youth Living with HIV in Long-Acting Antiretrovirals.
    J Acquir Immune Defic Syndr. 2018 Nov 8. doi: 10.1097/QAI.0000000000001896.
    PubMed     Text format     Abstract available


  10. FAYORSEY RN, Wang C, Chege D, Reidy W, et al
    Effectiveness of a lay counsellor-led combination intervention for retention of mothers and infants in HIV care: A randomized trial in Kenya.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001882.
    PubMed     Text format     Abstract available


  11. MEYA DB, Kiragga AN, Nalintya E, Morawski BM, et al
    Reflexive laboratory-based cryptococcal antigen screening and preemptive fluconazole therapy for cryptococcal antigenemia in HIV-infected individuals with CD4 <100 cells/microL: a stepped-wedge, cluster-randomized trial.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001894.
    PubMed     Text format     Abstract available


  12. BILLOCK RM, Powers KA, Pasquale DK, Samoff E, et al
    Prediction OF HIV Transmission Cluster Growth with Statewide Surveillance Data.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001905.
    PubMed     Text format     Abstract available


  13. PHILLIPS TK, Wilson IB, Brittain K, Zerbe A, et al
    Decreases in self-reported ART adherence predict HIV viremia among pregnant and postpartum South African women.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001909.
    PubMed     Text format     Abstract available


  14. JUMARE J, El-Kamary SS, Magder L, Hungerford L, et al
    Body Mass Index and Cognitive Function among HIV-1 Infected Individuals in China, India and Nigeria.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001906.
    PubMed     Text format     Abstract available


  15. FAINI D, Kalinjuma AV, Katende A, Mbwaji G, et al
    Laboratory-reflex cryptococcal antigen screening is associated with a survival benefit in Tanzania.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001899.
    PubMed     Text format     Abstract available


  16. EL KAMARI V, Sattar A, McComsey GA
    Gut structural damage, an ongoing process in chronically untreated HIV infection.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001910.
    PubMed     Text format     Abstract available


  17. COLON K, Speicher DW, Smith P, Taylor M, et al
    S100a14 is Increased in Activated Nk Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-Nk crosstalk.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001911.
    PubMed     Text format     Abstract available


  18. TORTELLI BA, Char DM, Crane JS, Powderly WG, et al
    Comfort discussing HIV pre-exposure prophylaxis with patients among physicians in an urban emergency department.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001890.
    PubMed     Text format    


  19. MASSANELLA M, Karris MY, Perez-Santiago J, Yek C, et al
    Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV.
    J Acquir Immune Defic Syndr. 2018;79:399-406.
    PubMed     Text format     Abstract available


  20. MAZHNAYA A, Marcus R, Bojko MJ, Zelenev A, et al
    Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
    J Acquir Immune Defic Syndr. 2018;79:288-295.
    PubMed     Text format     Abstract available


    October 2018
  21. RENTSCH CT, Tate JP, Steel T, Butt AA, et al
    Medical intensive care unit admission among patients with and without HIV, hepatitis C virus, and alcohol-related diagnoses in the United States: a national, retrospective cohort study, 1997-2014.
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001904.
    PubMed     Text format     Abstract available


  22. COSTAGLIOLA D, Potard V, Lang S, Abgrall S, et al
    Impact of antiretroviral drugs on fracture risk in HIV-infected individuals: A case-control study nested within the French Hospital Database on HIV (FHDH-ANRS CO4).
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001903.
    PubMed     Text format     Abstract available


  23. GRIFFITH D, Snyder J, Dell S, Nolan K, et al
    Impact of a youth-focused care model on retention and virologic suppression among young adults with HIV cared for in an adult HIV clinic.
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001902.
    PubMed     Text format     Abstract available


  24. BLUMENTHAL J, Jain S, Mulvihill E, Sun S, et al
    Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men.
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001888.
    PubMed     Text format     Abstract available


  25. LEWIS L, Maughan-Brown B, Grobler A, Cawood C, et al
    The impact of home-based HIV testing services on progress towards the UNAIDS 90-90-90 targets in a hyperendemic area of South Africa.
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001900.
    PubMed     Text format     Abstract available


  26. GHIGLIONE Y, Trifone C, Salido J, Rhodes A, et al
    PD-1 expression in HIV-specific CD8+ T-cells prior to antiretroviral therapy is associated with HIV persistence.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001887.
    PubMed     Text format     Abstract available


  27. SCHNOLL RA, Thompson M, Serrano K, Leone F, et al
    Rate of Nicotine Metabolism and Tobacco Use among Persons with HIV: Implications for Treatment and Research.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001895.
    PubMed     Text format     Abstract available


  28. ARRINGTON-SANDERS R, Wilson CM, Perumean-Chaney SE, Patki A 2nd, et al
    The role of socio-behavioral factors in sub-protective tenofovir diphosphate (TFV-DP) levels among YMSM enrolled in two PrEP trials.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001901.
    PubMed     Text format     Abstract available


  29. LAM A, Mayo NE, Scott S, Brouillette MJ, et al
    HIV-Related Stigma Affects Cognition in Older Men Living with HIV.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001898.
    PubMed     Text format     Abstract available


  30. CHOUDHARY RK, Wall KM, Njuguna I, Pavlinac PB, et al
    Monocyte-to-lymphocyte ratio is associated with tuberculosis disease and declines with anti-TB treatment in HIV-infected children.
    J Acquir Immune Defic Syndr. 2018 Oct 26. doi: 10.1097/QAI.0000000000001893.
    PubMed     Text format     Abstract available


  31. MUSTANSKI B, Morgan E, D'Aquila R, Birkett M, et al
    Individual and Network Factors Associated with Racial Disparities in HIV Among Young Men who have sex with Men: Results from the Radar Cohort Study.
    J Acquir Immune Defic Syndr. 2018 Oct 25. doi: 10.1097/QAI.0000000000001886.
    PubMed     Text format     Abstract available


  32. MONTOYA JL, Campbell LM, Paolillo EW, Ellis RJ, et al
    Inflammation Relates to Poorer Complex Motor Performance among Adults Living with HIV on Suppressive Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 Oct 25. doi: 10.1097/QAI.0000000000001881.
    PubMed     Text format     Abstract available


  33. GIANELLA S, Marconi VC, Berzins B, Benson CA, et al
    Genital HIV-1 Shedding with Dolutegravir (DTG) plus Lamivudine (3TC) Dual Therapy.
    J Acquir Immune Defic Syndr. 2018 Oct 23. doi: 10.1097/QAI.0000000000001863.
    PubMed     Text format    


  34. LEMONS A, DeGroote N, Perez A, Craw J, et al
    Opioid Misuse among HIV-Positive Adults in Medical Care: Results from the Medical Monitoring Project, 2009 - 2014.
    J Acquir Immune Defic Syndr. 2018 Oct 23. doi: 10.1097/QAI.0000000000001889.
    PubMed     Text format     Abstract available


  35. MAKANANI B, Balkus JE, Jiao Y, Noguchi LM, et al
    Pregnancy and infant outcomes among women using the dapivirine vaginal ring in early pregnancy.
    J Acquir Immune Defic Syndr. 2018 Oct 23. doi: 10.1097/QAI.0000000000001861.
    PubMed     Text format     Abstract available


  36. SHRESTHA R, Altice FL, Copenhaver MM
    HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence among HIV-Positive Methadone-Maintained Patients.
    J Acquir Immune Defic Syndr. 2018 Oct 23. doi: 10.1097/QAI.0000000000001891.
    PubMed     Text format     Abstract available


  37. BURNETT SM, Zawedde-Muyanja S, Hermans SM, Weaver MR, et al
    Effect of TB/HIV Integration on TB and HIV indicators in Rural Ugandan Health Facilities.
    J Acquir Immune Defic Syndr. 2018 Oct 23. doi: 10.1097/QAI.0000000000001862.
    PubMed     Text format     Abstract available


  38. STREED CG JR, Goldstein Z, Poteat T, Mukherjee M, et al
    Response to: Cardiovascular Risk Profile of Transgender Women with HIV.
    J Acquir Immune Defic Syndr. 2018 Oct 10. doi: 10.1097/QAI.0000000000001884.
    PubMed     Text format    


  39. MILAM J, Jain S, Dube MP, Daar ES, et al
    Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study among Individuals at Risk for HIV.
    J Acquir Immune Defic Syndr. 2018 Oct 10. doi: 10.1097/QAI.0000000000001885.
    PubMed     Text format     Abstract available


  40. MOORHOUSE M, Maartens G, Francois Venter WD, Moosa MY, et al
    Third-line antiretroviral therapy programme in the South African public sector: cohort description and virological outcomes.
    J Acquir Immune Defic Syndr. 2018 Oct 10. doi: 10.1097/QAI.0000000000001883.
    PubMed     Text format     Abstract available


  41. LEE WK, Milloy MJS, Nosova E, Walsh J, et al
    Predictors of antiretroviral adherence self-efficacy among people living with HIV/AIDS in a Canadian setting.
    J Acquir Immune Defic Syndr. 2018 Oct 5. doi: 10.1097/QAI.0000000000001878.
    PubMed     Text format     Abstract available


  42. RONIT A, Ahlstrom MG, Knudsen AD, Gerstoft J, et al
    HIV Status Is a Greater Determinant of Low Self-perceived Life Expectancy Than Cigarette Smoking in a Well-resourced Setting.
    J Acquir Immune Defic Syndr. 2018;79:e81-e84.
    PubMed     Text format    


  43. O'CLEIRIGH C, Zvolensky MJ, Smits JAJ, Labbe AK, et al
    Integrated Treatment for Smoking Cessation, Anxiety, and Depressed Mood in People Living With HIV: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2018;79:261-268.
    PubMed     Text format     Abstract available


  44. GREENHALGH S, Hobbs CV, Parikh S
    Brief Report: Antimalarial Benefit of HIV Antiretroviral Therapy in Areas of Low to Moderate Malaria Transmission Intensity.
    J Acquir Immune Defic Syndr. 2018;79:249-254.
    PubMed     Text format     Abstract available


  45. CHINTANAPHOL M, Sacdalan C, Chottanapund S, Pinyakorn S, et al
    Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in Thailand.
    J Acquir Immune Defic Syndr. 2018;79:244-248.
    PubMed     Text format     Abstract available


  46. NKHOMA K, Norton C, Sabin C, Winston A, et al
    Self-management Interventions for Pain and Physical Symptoms Among People Living With HIV: A Systematic Review of the Evidence.
    J Acquir Immune Defic Syndr. 2018;79:206-225.
    PubMed     Text format     Abstract available


  47. ROUX P, Fressard L, Suzan-Monti M, Chas J, et al
    Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY Trial.
    J Acquir Immune Defic Syndr. 2018;79:e69-e75.
    PubMed     Text format     Abstract available


  48. NWANGWU-IKE N, Frazier EL, Crepaz N, Tie Y, et al
    Racial and Ethnic Differences in Viral Suppression Among HIV-Positive Women in Care.
    J Acquir Immune Defic Syndr. 2018;79:e56-e68.
    PubMed     Text format     Abstract available


  49. YEN YF, Feng JY, Yi-Fong Su V, Chuang PH, et al
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Uveitis Among People Living With HIV/AIDS.
    J Acquir Immune Defic Syndr. 2018;79:149-157.
    PubMed     Text format     Abstract available


  50. DHANDE J, Angadi M, Murugavel KG, Poongulali S, et al
    Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
    J Acquir Immune Defic Syndr. 2018;79:277-282.
    PubMed     Text format     Abstract available


  51. TAGARRO A, Chan M, Zangari P, Ferns B, et al
    Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children.
    J Acquir Immune Defic Syndr. 2018;79:269-276.
    PubMed     Text format     Abstract available


  52. SADOH A, Eki-Udoko FE
    Cotransmission of Malaria and HIV to Infants of Mothers Coinfected With Malaria and HIV in the HAART Era in Benin City, Nigeria.
    J Acquir Immune Defic Syndr. 2018;79:255-260.
    PubMed     Text format     Abstract available


  53. LE MARCIS F
    Postface: Meaning of the Experiment and Implications of the Experience.
    J Acquir Immune Defic Syndr. 2018;79 Suppl 1:S69-S73.
    PubMed     Text format     Abstract available


  54. FILLIEULE O
    Logics of Commitment in Vaccine Trials of the ANRS Cohorts 1992-2001.
    J Acquir Immune Defic Syndr. 2018;79 Suppl 1:S59-S68.
    PubMed     Text format     Abstract available


  55. GIAMI A, Linard F
    HIV Vaccine Trials: Ethical, Psychological, and Psychological-Social Aspects (1991-1996).
    J Acquir Immune Defic Syndr. 2018;79 Suppl 1:S51-S58.
    PubMed     Text format     Abstract available


  56. DURIER C, Desaint C, Launay O
    Social and Behavioral Consequences of Participation in HIV Preventive Vaccine Trials in the ANRS COHVAC Cohort.
    J Acquir Immune Defic Syndr. 2018;79 Suppl 1:S37-S50.
    PubMed     Text format     Abstract available


  57. COTTINGHAM MD, Kalbaugh JM, Swezey T, Fisher JA, et al
    Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials.
    J Acquir Immune Defic Syndr. 2018;79 Suppl 1:S30-S36.
    PubMed     Text format     Abstract available


  58. COUDERC M
    Being "False Positive": An "Inconvenience"? Debates and Questions Regarding the Notion of Vaccine-Induced Seropositivity (VISP) in the Recruitment of Healthy Volunteers for a Preventive Anti-HIV Vaccine Trial.
    J Acquir Immune Defic Syndr. 2018;79 Suppl 1:S20-S29.
    PubMed     Text format     Abstract available


  59. OLLIVIER-YANIV C
    Recruitment and Engagement in Preventive Clinical Trials: Interdependencies and Mediation.
    J Acquir Immune Defic Syndr. 2018;79 Suppl 1:S3-S7.
    PubMed     Text format     Abstract available


  60. WANG R, Shlipak MG, Ix JH, Brown TT, et al
    The Association of Fibroblast Growth Factor-23 (FGF-23) with Incident Frailty in HIV-Infected and -Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2018 Oct 1. doi: 10.1097/QAI.0000000000001868.
    PubMed     Text format     Abstract available


  61. ROBERTSON MM, Penrose K, Irvine MK, Robbins RS, et al
    Impact of an HIV Care Coordination Program on Durable Viral Suppression.
    J Acquir Immune Defic Syndr. 2018 Oct 1. doi: 10.1097/QAI.0000000000001877.
    PubMed     Text format     Abstract available


    September 2018
  62. OBIMBO MM, Zhou Y, Mcmaster MT, Cohen CR, et al
    Placental structure in preterm birth amongst HIV positive versus negative women in Kenya.
    J Acquir Immune Defic Syndr. 2018 Sep 27. doi: 10.1097/QAI.0000000000001871.
    PubMed     Text format     Abstract available


  63. REFUGIO ON, Kimble MM, Silva CL, Lykens JE, et al
    PrEPTECH: a telehealth-based initiation program for human immunodeficiency virus pre-exposure prophylaxis in young men of color who have sex with men. A pilot study of feasibility.
    J Acquir Immune Defic Syndr. 2018 Sep 27. doi: 10.1097/QAI.0000000000001873.
    PubMed     Text format     Abstract available


  64. CHANG AY, Haber N, Barnighausen T, Herbst K, et al
    Improving the validity of mathematical models for HIV elimination by incorporating empirical estimates of progression through the HIV treatment cascade.
    J Acquir Immune Defic Syndr. 2018 Sep 27. doi: 10.1097/QAI.0000000000001852.
    PubMed     Text format     Abstract available


  65. HAKKERS CS, Arends JE, van den Berk GE, Ensing MHM, et al
    Objective and Subjective Improvement of Cognition After Discontinuing Efavirenz in Asymptomatic Patients: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2018 Sep 24. doi: 10.1097/QAI.0000000000001876.
    PubMed     Text format     Abstract available


  66. TURAN B, Crockett KB, Kempf MC, Konkle-Parker D, et al
    Internal Working Models of Attachment Relationships and HIV Outcomes among Women Living with HIV.
    J Acquir Immune Defic Syndr. 2018 Sep 24. doi: 10.1097/QAI.0000000000001872.
    PubMed     Text format     Abstract available


  67. DADABHAI S, Gadama Fcog L, Chamanga R, Kawalazira R, et al
    Pregnancy outcomes in the era of universal antiretroviral treatment in sub-Saharan Africa (POISE Study).
    J Acquir Immune Defic Syndr. 2018 Sep 24. doi: 10.1097/QAI.0000000000001875.
    PubMed     Text format     Abstract available


  68. BRETANA N, Gray R, Law M, Guy R, et al
    Aging of the HIV Population in Australia: A modeling study.
    J Acquir Immune Defic Syndr. 2018 Sep 21. doi: 10.1097/QAI.0000000000001870.
    PubMed     Text format    


  69. DANDACHI D, May SB, Davila JA, Cully JY, et al
    The Association of Unmet Needs with Subsequent Retention in Care and HIV Suppression Among Hospitalized Patients with HIV Who Are Out of Care.
    J Acquir Immune Defic Syndr. 2018 Sep 21. doi: 10.1097/QAI.0000000000001874.
    PubMed     Text format     Abstract available


  70. MANSERGH G, Baack BN, Holman J, Mimiaga MJ, et al
    Quantitative assessment of brief messages about HIV pre-exposure prophylaxis among HIV-infected and HIV-uninfected black/African American and Hispanic/Latino MSM.
    J Acquir Immune Defic Syndr. 2018 Sep 21. doi: 10.1097/QAI.0000000000001869.
    PubMed     Text format     Abstract available


  71. COLIE C, Michel KG, Massad LS, Wang MC, et al
    Natural history of cervical intraepithelial neoplasia-2 in HIV-positive women of reproductive age.
    J Acquir Immune Defic Syndr. 2018 Sep 21. doi: 10.1097/QAI.0000000000001865.
    PubMed     Text format     Abstract available


  72. CARRICO AW, Hunt PW, Neilands TB, Dilworth SE, et al
    Stimulant Use and Viral Suppression In the Era of Universal Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 Sep 21. doi: 10.1097/QAI.0000000000001867.
    PubMed     Text format     Abstract available


  73. PALANEE-PHILLIPS T, Roberts ST, Reddy K, Vaneshree Govender, et al
    Impact of partner-related social harms on women's adherence to the dapivirine vaginal ring during a phase III trial.
    J Acquir Immune Defic Syndr. 2018 Sep 18. doi: 10.1097/QAI.0000000000001866.
    PubMed     Text format     Abstract available


  74. SINGH RP, Shaik JSB, Skoura N, Joshi S, et al
    Effects of Low- and High-Mineral Content Water on the Relative Bioavailability of a Coformulated Abacavir/Dolutegravir/Lamivudine Dispersible Tablet in Healthy Adults.
    J Acquir Immune Defic Syndr. 2018 Sep 14. doi: 10.1097/QAI.0000000000001859.
    PubMed     Text format     Abstract available


  75. RAFFUL C, Jain S, Sun X, Strathdee SA, et al
    Identification of a Syndemic of Blood-Borne Disease Transmission and Injection drug Use Initiation at the US-Mexico Border.
    J Acquir Immune Defic Syndr. 2018 Sep 14. doi: 10.1097/QAI.0000000000001858.
    PubMed     Text format     Abstract available


  76. WORODRIA W, Emily C, Andama A, Sanyu I, et al
    Predictors of Mortality among Hospitalized Patients with Lower Respiratory Tract Infections in a High HIV Burden Setting.
    J Acquir Immune Defic Syndr. 2018 Sep 14. doi: 10.1097/QAI.0000000000001855.
    PubMed     Text format     Abstract available


  77. THURMAN A, Schwartz JL, Brache V, Chen BA, et al
    The Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate users.
    J Acquir Immune Defic Syndr. 2018 Sep 11. doi: 10.1097/QAI.0000000000001864.
    PubMed     Text format     Abstract available


  78. YUENGLING KA, Padayatchi N, Wolf A, Mathema B, et al
    Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug Resistant Tuberculosis (XDR-TB) HIV Co-Infection Treatment in KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2018 Sep 11. doi: 10.1097/QAI.0000000000001833.
    PubMed     Text format     Abstract available


  79. OSTER AM, France AM, Panneer N, Banez Ocfemia MC, et al
    Identifying Clusters of Recent and Rapid HIV Transmission Through Analysis of Molecular Surveillance Data.
    J Acquir Immune Defic Syndr. 2018 Sep 7. doi: 10.1097/QAI.0000000000001856.
    PubMed     Text format     Abstract available


  80. GROVER S, Desir F, Jing Y, Bhatia RK, et al
    Reduced cancer survival among adults with HIV and an AIDS-defining illnesses despite no difference in cancer stage at diagnosis.
    J Acquir Immune Defic Syndr. 2018 Sep 5. doi: 10.1097/QAI.0000000000001842.
    PubMed     Text format     Abstract available


  81. KAPOGIANNIS BG, Nelson RM, Siberry GK, Lee S, et al
    Advancing HIV Biomedical Prevention Research for At-Risk Adolescents.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001853.
    PubMed     Text format     Abstract available


  82. MCMAHON BA, Hanouneh M, Chedid A, Fine DM, et al
    Association of HIV Suppression with Kidney Disease Progression among HIV-Positive African Americans with Biopsy-Proven Classic FSGS.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001860.
    PubMed     Text format     Abstract available


  83. PINTYE J, Kinuthia J, Roberts DA, Wagner AD, et al
    Integration of PrEP Services Into Routine Antenatal and Postnatal care: Experiences from an Implementation Program in Western Kenya.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001850.
    PubMed     Text format     Abstract available


  84. PARENT S, Barrios R, Nosyk B, Ye M, et al
    The Impact Of Patient-Provider Attachment On Hospital Readmissions Among People Living With Hiv: A Population-Based Study.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001857.
    PubMed     Text format     Abstract available


  85. MUCCINI C, Galli L, Poli A, Carbone A, et al
    Hyperbilirubinemia is Associated with A Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients On Virological Suppression.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001854.
    PubMed     Text format     Abstract available


  86. NARLA V, Bhakta N, Freedman JE, Tanriverdi K, et al
    Unique Circulating MicroRNA profiles in HIV Infection.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001851.
    PubMed     Text format     Abstract available


  87. GEORGE EC, Bucciardini R, Richert L, Dedes N, et al
    Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results from NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination with Tenofovir/Emtricitabine or Raltegravir.
    J Acquir Immune Defic Syndr. 2018 Sep 3. doi: 10.1097/QAI.0000000000001844.
    PubMed     Text format     Abstract available



  88. Integrating HIV and Maternal, Neonatal and Child Health Services in Rural Malawi: An Evaluation of the Implementation Processes and Challenges: Erratum.
    J Acquir Immune Defic Syndr. 2018;79:e51.
    PubMed     Text format    


    August 2018
  89. HAWKINS KL, Gordon KS, Levin MJ, Weinberg A, et al
    Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living with and without HIV in the Veterans Aging Cohort Study.
    J Acquir Immune Defic Syndr. 2018 Aug 28. doi: 10.1097/QAI.0000000000001846.
    PubMed     Text format     Abstract available


  90. BURGOS J, Martin-Castillo M, Landolfi S, Dinares M, et al
    The Effectiveness of Trichloroacetic Acid vs Electrocautery Ablation for the Treatment of anal High-grade squamous intraepithelial lesion in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2018 Aug 28. doi: 10.1097/QAI.0000000000001847.
    PubMed     Text format     Abstract available


  91. SUPERVIE V, Breban R
    Per Sex-Act Risk of HIV Transmission Under Antiretroviral Treatment: A Data-Driven Approach.
    J Acquir Immune Defic Syndr. 2018 Aug 28. doi: 10.1097/QAI.0000000000001845.
    PubMed     Text format     Abstract available


  92. AMMASSARI A, Stohr W, Antinori A, Molina JM, et al
    Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined with Either Raltegravir or Tenofovir Disoproxil Fumarate /Emtricitabine in the Neat 001/Anrs 143 Trial.
    J Acquir Immune Defic Syndr. 2018 Aug 27. doi: 10.1097/QAI.0000000000001834.
    PubMed     Text format     Abstract available


  93. DAVY-MENDEZ T, Napravnik S, Zakharova O, Kuruc J, et al
    Acute HIV Infection and CD4/CD8 Ratio Normalization after Antiretroviral Therapy Initiation.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001843.
    PubMed     Text format     Abstract available


  94. LI Y, Nouraie SM, Kessinger C, Weinman R, et al
    Factors Associated with Progression of Lung Function Abnormalities in HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001840.
    PubMed     Text format     Abstract available


  95. OLDENBURG CE, Ortblad KF, Chanda MM, Mwale M, et al
    Intimate Partner Violence and Antiretroviral Therapy Initiation Among Female Sex Workers Newly Diagnosed with HIV in ZAMBIA: A Prospective Study.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001841.
    PubMed     Text format     Abstract available


  96. JALIL EM, Grinsztejn B, Velasque L, Makkeda AR, et al
    Awareness, willingness and PrEP eligibility among transgender women in Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001839.
    PubMed     Text format     Abstract available


  97. GICHANGI A, Wambua J, Mutwiwa S, Njogu R, et al
    Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001838.
    PubMed     Text format     Abstract available


  98. MARK D, Geng E, Vorkoper S, Essajee S, et al
    Making Implementation Science Work for Children and Adolescents Living With HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S58-S62.
    PubMed     Text format     Abstract available


  99. CIARANELLO A, Sohn AH, Collins IJ, Rothery C, et al
    Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S49-S57.
    PubMed     Text format     Abstract available


  100. FORD D, Turner R, Turkova A, Penazzato M, et al
    Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S40-S48.
    PubMed     Text format     Abstract available


  101. ABRAMS EJ, Ananworanich J, Archary M, Ngongondo M, et al
    Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S32-S39.
    PubMed     Text format     Abstract available


  102. OLIVERAS C, Cluver L, Bernays S, Armstrong A, et al
    Nothing About Us Without RIGHTS-Meaningful Engagement of Children and Youth: From Research Prioritization to Clinical Trials, Implementation Science, and Policy.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S27-S31.
    PubMed     Text format     Abstract available


  103. SOHN AH, Judd A, Mofenson L, Vicari M, et al
    Using Observational Data to Inform HIV Policy Change for Children and Youth.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S22-S26.
    PubMed     Text format     Abstract available


  104. ARMSTRONG A, Nagata JM, Vicari M, Irvine C, et al
    A Global Research Agenda for Adolescents Living With HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S16-S21.
    PubMed     Text format     Abstract available


  105. PENAZZATO M, Irvine C, Vicari M, Essajee SM, et al
    A Global Research Agenda for Pediatric HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S10-S15.
    PubMed     Text format     Abstract available


  106. IRVINE C, Armstrong A, Nagata JM, Rollins N, et al
    Setting Global Research Priorities in Pediatric and Adolescent HIV Using the Child Health and Nutrition Research Initiative (CHNRI) Methodology.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S3-S9.
    PubMed     Text format     Abstract available


  107. BEKKER LG, Siberry GK, Hirnschall G
    Ensuring Children and Adolescents Are Not Left Behind.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S1-S2.
    PubMed     Text format    


  108. KALIEL D, McCarthy E, Tayag J, Berry A, et al
    Sustainability and Accelerating Children's HIV/AIDS Treatment (ACT) Initiative: Lessons for the Next Treatment Surge.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S142-S146.
    PubMed     Text format     Abstract available


  109. SAITO S, Chung H, Mahy M, Radin AK, et al
    Pediatric HIV Treatment Gaps in 7 East and Southern African Countries: Examination of Modeled, Survey, and Routine Program Data.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S134-S141.
    PubMed     Text format     Abstract available


  110. PENAZZATO M, Sugandhi N, Essajee S, Doherty M, et al
    Getting Treatment and Care Services Right for Children and Adolescents to Reach High Viral Suppression.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S128-S133.
    PubMed     Text format     Abstract available


  111. GRIMSRUD A, Bygrave H, Wilkinson L
    For Family-Centered Differentiated Service Delivery for HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S124-S127.
    PubMed     Text format     Abstract available


  112. WILLIS N, Napei T, Armstrong A, Jackson H, et al
    Zvandiri-Bringing a Differentiated Service Delivery Program to Scale for Children, Adolescents, and Young People in Zimbabwe.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S115-S123.
    PubMed     Text format     Abstract available


  113. MODI S, Broyles LN, Montandon M, Itoh M, et al
    Beyond Early Infant Diagnosis: Changing the Approach to HIV-Exposed Infants.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S107-S114.
    PubMed     Text format     Abstract available


  114. MEDLEY AM, Hrapcak S, Golin RA, Dziuban EJ, et al
    Strategies for Identifying and Linking HIV-Infected Infants, Children, and Adolescents to HIV Treatment Services in Resource Limited Settings.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S98-S106.
    PubMed     Text format     Abstract available


  115. SIMON KR, Flick RJ, Kim MH, Sabelli RA, et al
    Family Testing: An Index Case Finding Strategy to Close the Gaps in Pediatric HIV Diagnosis.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S88-S97.
    PubMed     Text format     Abstract available


  116. AMZEL A, Srivastava M, Isavwa A, Sanders J, et al
    Community-Based Interventions to Reach 95-95-95 for Children and Adolescents: An Exploratory Programmatic Review From Lesotho.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S81-S87.
    PubMed     Text format     Abstract available


  117. KIM MH, Wanless RS, Caviness AC, Golin R, et al
    Multimonth Prescription of Antiretroviral Therapy Among Children and Adolescents: Experiences From the Baylor International Pediatric AIDS Initiative in 6 African Countries.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S71-S80.
    PubMed     Text format     Abstract available


  118. HARRISON K, Robinson J, Marks L, Blander J, et al
    ACTing in Partnership to Accelerate Impact.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S65-S70.
    PubMed     Text format     Abstract available


  119. SIBERRY GK, Amzel A, Watts DH, Ahmed S, et al
    Supplement Introduction: Accelerating Children's HIV/AIDS Treatment (ACT) Initiative: Using What We Learned to Maintain the Pace to Close the Pediatric HIV Treatment Gap.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S63-S64.
    PubMed     Text format    


  120. BECKER ML, Bhattacharjee P, Blanchard JF, Cheuk E, et al
    Vulnerabilities at first sex and their association with lifetime gender-based violence and HIV prevalence among adolescent girls and young women engaged in sex work, transactional sex, and casual sex in Kenya.
    J Acquir Immune Defic Syndr. 2018 Aug 10. doi: 10.1097/QAI.0000000000001826.
    PubMed     Text format     Abstract available


  121. BUKOWSKI LA, Chandler CJ, Creasy SL, Matthews DD, et al
    Characterizing the HIV Care Continuum and Identifying Barriers and Facilitators to HIV Diagnosis and Viral Suppression among Black Transgender Women in the United States.
    J Acquir Immune Defic Syndr. 2018 Aug 2. doi: 10.1097/QAI.0000000000001831.
    PubMed     Text format     Abstract available


  122. SHARMA A, Ma Y, Tien PC, Scherzer R, et al
    HIV Infection Is Associated With Abnormal Bone Microarchitecture: Measurement of Trabecular Bone Score in the Women's Interagency HIV Study.
    J Acquir Immune Defic Syndr. 2018;78:441-449.
    PubMed     Text format     Abstract available


  123. BRANSTROM R, Pachankis JE
    Validating the Syndemic Threat Surrounding Sexual Minority Men's Health in a Population-Based Study With National Registry Linkage and a Heterosexual Comparison.
    J Acquir Immune Defic Syndr. 2018;78:376-382.
    PubMed     Text format     Abstract available


  124. PASQUALE DK, Doherty IA, Sampson LA, Hue S, et al
    Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks.
    J Acquir Immune Defic Syndr. 2018;78:367-375.
    PubMed     Text format     Abstract available


  125. SPINELLI MA, Scott HM, Vittinghoff E, Liu AY, et al
    A Panel Management and Patient Navigation Intervention is Associated with Earlier PrEP Initiation in A Safety-Net Primary Care Health System.
    J Acquir Immune Defic Syndr. 2018 Aug 1. doi: 10.1097/QAI.0000000000001828.
    PubMed     Text format     Abstract available


  126. CHRISTENSEN-QUICK A, Chaillon A, Yek C, Zanini F, et al
    Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 Aug 1. doi: 10.1097/QAI.0000000000001829.
    PubMed     Text format    


  127. ROSENBERG NE, Bhushan NL, Vansia D, Phanga T, et al
    Comparing Youth Friendly Health Services to the Standard of Care through "Girl Power-Malawi": A Quasi-Experimental Cohort Study.
    J Acquir Immune Defic Syndr. 2018 Aug 1. doi: 10.1097/QAI.0000000000001830.
    PubMed     Text format     Abstract available


    July 2018
  128. OLSON A, Ragan EJ, Nakiyingi L, Lin N, et al
    Pulmonary Tuberculosis is Associated with Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Co-Infected Ugandans.
    J Acquir Immune Defic Syndr. 2018 Jul 26. doi: 10.1097/QAI.0000000000001823.
    PubMed     Text format     Abstract available


  129. KAYONGO A, Gonzalo-Gil E, Gumusgoz E, Niwaha AJ, et al
    Identification of Elite and Viremic Controllers from a Large Urban HIV Ambulatory Center in Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2018 Jul 26. doi: 10.1097/QAI.0000000000001825.
    PubMed     Text format     Abstract available


  130. VELLOZA J, Baeten JM, Haberer J, Ngure K, et al
    The Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa.
    J Acquir Immune Defic Syndr. 2018 Jul 25. doi: 10.1097/QAI.0000000000001821.
    PubMed     Text format     Abstract available


  131. EATON LA, Matthews DD, Bukowski LA, Friedman MR, et al
    Elevated HIV Prevalence and Correlates of PrEP Use Among a Community Sample of Black Men who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2018 Jul 25. doi: 10.1097/QAI.0000000000001822.
    PubMed     Text format     Abstract available


  132. KOSE J, Tiam A, Ochuka B, Okoth E, et al
    Impact of a Comprehensive Adolescent-Focused Case Finding Intervention on Uptake of HIV Testing and Linkage to Care among Adolescents in Western Kenya.
    J Acquir Immune Defic Syndr. 2018 Jul 25. doi: 10.1097/QAI.0000000000001819.
    PubMed     Text format     Abstract available


  133. GOEDEL WC, King MRF, Lurie MN, Nunn AS, et al
    Effect of Racial Inequities in Pre-Exposure Prophylaxis Use on Racial Disparities in HIV Incidence Among Men Who Have Sex with Men: A Modeling Study.
    J Acquir Immune Defic Syndr. 2018 Jul 20. doi: 10.1097/QAI.0000000000001817.
    PubMed     Text format     Abstract available


  134. JESPERSEN S, Honge BL, Krarup H, Medstrand P, et al
    Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): a Randomised Controlled Trial.
    J Acquir Immune Defic Syndr. 2018 Jul 20. doi: 10.1097/QAI.0000000000001820.
    PubMed     Text format     Abstract available


  135. MACKESY-AMITI ME, Boodram B, Handanagic S, Paz-Bailey G, et al
    Latent Classes of Sexual Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Among Women who Inject Drugs Across 20 u.s. Cities.
    J Acquir Immune Defic Syndr. 2018 Jul 20. doi: 10.1097/QAI.0000000000001816.
    PubMed     Text format     Abstract available


  136. DELANEY JA, Nance RM, Whitney BM, Altice FL, et al
    Reduced use of illicit substances, even without abstinence, is associated with improved depressive symptoms among people living with HIV.
    J Acquir Immune Defic Syndr. 2018 Jul 19. doi: 10.1097/QAI.0000000000001803.
    PubMed     Text format     Abstract available


  137. NAPIERALA S, Chabata ST, Fearon E, Davey C, et al
    Engagement in HIV Care Among young female sex workers in Zimbabwe.
    J Acquir Immune Defic Syndr. 2018 Jul 19. doi: 10.1097/QAI.0000000000001815.
    PubMed     Text format     Abstract available


  138. LIN TC, Dijkstra M, De Bree GJ, Schim van der Loeff MF, et al
    The Amsterdam Symptom and Risk-Based Score Predicts for Acute HIV Infection in Men who Have Sex with Men in San Diego.
    J Acquir Immune Defic Syndr. 2018 Jul 10. doi: 10.1097/QAI.0000000000001800.
    PubMed     Text format     Abstract available


  139. KACANEK D, Williams PL, Mayondi G, Holding P, et al
    Pediatric Neurodevelopmental Functioning Following in utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana.
    J Acquir Immune Defic Syndr. 2018 Jul 10. doi: 10.1097/QAI.0000000000001799.
    PubMed     Text format     Abstract available


  140. MOUCHERAUD C, Chasweka D, Nyirenda M, Schooley A, et al
    A Simple Screening Tool May Help Identify High-Risk Children for Targeted HIV Testing in Malawian Inpatient Wards.
    J Acquir Immune Defic Syndr. 2018 Jul 9. doi: 10.1097/QAI.0000000000001804.
    PubMed     Text format     Abstract available


  141. CHOW FC, Wang H, Li Y, Mehta N, et al
    Cerebral Vasoreactivity Evaluated by the Breath Holding Challenge Correlates with Performance on A Cognitive Screening Test in Persons Living with Treated HIV Infection in China.
    J Acquir Immune Defic Syndr. 2018 Jul 9. doi: 10.1097/QAI.0000000000001805.
    PubMed     Text format    


  142. CHEN M, Yen YF, Lan YC, Jen IA, et al
    Risk of Diffuse Infiltrative Lymphocytosis Syndrome in HIV-Infected Patients: A Nationwide Population-Based Cohort Study.
    J Acquir Immune Defic Syndr. 2018 Jul 9. doi: 10.1097/QAI.0000000000001802.
    PubMed     Text format     Abstract available


  143. MACDONALD DM, Melzer AC, Collins G, Avihingsanon A, et al
    Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the Start Pulmonary Substudy.
    J Acquir Immune Defic Syndr. 2018 Jul 6. doi: 10.1097/QAI.0000000000001797.
    PubMed     Text format     Abstract available


  144. CHANG E, Mapakshi SR, Mbang P, El-Mallawany NK, et al
    The impact of protease inhibitors on HIV-associated Kaposi sarcoma incidence: a systematic review.
    J Acquir Immune Defic Syndr. 2018 Jul 6. doi: 10.1097/QAI.0000000000001798.
    PubMed     Text format     Abstract available


  145. APONDI E, Humphrey JM, Sang E, Mwangi A, et al
    Trends Over Time for Adolescents Enrolling in HIV Care in Kenya, Tanzania, and Uganda from 2001-2014.
    J Acquir Immune Defic Syndr. 2018 Jul 4. doi: 10.1097/QAI.0000000000001796.
    PubMed     Text format     Abstract available


  146. BEHRENDS CN, Nugent AV, Des Jarlais DC, Frimpong JA, et al
    Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.
    J Acquir Immune Defic Syndr. 2018 Jul 3. doi: 10.1097/QAI.0000000000001792.
    PubMed     Text format    


  147. ZHANG Y, Sivay MV, Hudelson SE, Clarke W, et al
    Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068.
    J Acquir Immune Defic Syndr. 2018 Jul 3. doi: 10.1097/QAI.0000000000001793.
    PubMed     Text format     Abstract available


  148. KNUDSEN AD, Gelpi M, Afzal S, Ronit A, et al
    Prevalence of Peripheral Artery Disease is Higher in Persons Living with HIV Compared to Uninfected Controls.
    J Acquir Immune Defic Syndr. 2018 Jul 3. doi: 10.1097/QAI.0000000000001795.
    PubMed     Text format     Abstract available


    June 2018
  149. REYNIERS T, Nostlinger C, Laga M, De Baetselier I, et al
    Choosing between Daily and Event-Driven Pre-Exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project.
    J Acquir Immune Defic Syndr. 2018 Jun 29. doi: 10.1097/QAI.0000000000001791.
    PubMed     Text format     Abstract available


  150. PAUL RH, Cooley SA, Garcia-Egan PM, Ances BM, et al
    Cognitive Performance and Frailty in Older HIV-Positive Adults.
    J Acquir Immune Defic Syndr. 2018 Jun 26. doi: 10.1097/QAI.0000000000001790.
    PubMed     Text format     Abstract available


  151. TAGARRO A, Chan M, Zangari P, Ferns B, et al
    Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children.
    J Acquir Immune Defic Syndr. 2018 Jun 26. doi: 10.1097/QAI.0000000000001789.
    PubMed     Text format     Abstract available


  152. CHIAPPINI E, Galli L, Lisi C, Gabiano C, et al
    Strategies for prevention of mother-to-child transmission adopted in the "real world" setting: data from the Italian Register for HIV-1 infection in children.
    J Acquir Immune Defic Syndr. 2018 Jun 26. doi: 10.1097/QAI.0000000000001774.
    PubMed     Text format     Abstract available


  153. KERKERIAN G, Kestler M, Carter A, Wang L, et al
    Attrition across the HIV cascade of care among a diverse cohort of women living with HIV in Canada.
    J Acquir Immune Defic Syndr. 2018 Jun 15. doi: 10.1097/QAI.0000000000001775.
    PubMed     Text format     Abstract available


  154. CAMPOS NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, et al
    Cost-effectiveness of cervical cancer screening in women living with HIV in South Africa: A mathematical modeling study.
    J Acquir Immune Defic Syndr. 2018 Jun 15. doi: 10.1097/QAI.0000000000001778.
    PubMed     Text format     Abstract available


  155. CALVET GA, Brasil P, Siqueira AM, Zogbi HE, et al
    Zika Virus Infection and Differential Diagnosis in A Cohort of HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2018 Jun 14. doi: 10.1097/QAI.0000000000001777.
    PubMed     Text format     Abstract available


  156. HART SA, Vardhanabhuti S, Strobino SA, Harrison LJ, et al
    The Impact of Changes over Time in the Stanford University Genotypic Resistance Interpretation Algorithm.
    J Acquir Immune Defic Syndr. 2018 Jun 14. doi: 10.1097/QAI.0000000000001776.
    PubMed     Text format     Abstract available


  157. GOH SM, Williams J, Pannu N, Costello K, et al
    Are Bone Disease and Cardiovascular Disease Risk Correlated in an HIV Cohort?
    J Acquir Immune Defic Syndr. 2018 Jun 12. doi: 10.1097/QAI.0000000000001771.
    PubMed     Text format    


  158. LALLEY-CHARECZKO L, Clark D, Conyngham SC, Zuppa A, et al
    Delivery of TDF/FTC for Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition in Young Adult Men Who Have Sex with Men and Transgender Women of Color using a Urine Adherence Assay.
    J Acquir Immune Defic Syndr. 2018 Jun 12. doi: 10.1097/QAI.0000000000001772.
    PubMed     Text format     Abstract available


  159. PIERCE JD, Ylitalo KR, Lanning BA, Limbers CC, et al
    Sex Education and HIV Testing Among Young Men who Have Sex with Men: Findings From The 2006-2010 and 2011-2015 National Survey of Family Growth.
    J Acquir Immune Defic Syndr. 2018 Jun 12. doi: 10.1097/QAI.0000000000001773.
    PubMed     Text format     Abstract available


  160. THIRUMURTHY H, Masters SH, Agot K
    Willingness to Pay for HIV Self-Tests Among Women in Kenya: Implications for Subsidy and Pricing Policies.
    J Acquir Immune Defic Syndr. 2018;78:e8-e11.
    PubMed     Text format    


  161. RANZANI A, Oreni L, Agro M, van den Bogaart L, et al
    Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    J Acquir Immune Defic Syndr. 2018;78:193-201.
    PubMed     Text format     Abstract available


  162. JUSTMAN JE, Nair GL, Hendrix CW, Piper JM, et al
    Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.
    J Acquir Immune Defic Syndr. 2018;78:175-182.
    PubMed     Text format     Abstract available


  163. JOTWANI V, Scherzer R, Glidden DV, Mehrotra M, et al
    Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2018;78:169-174.
    PubMed     Text format     Abstract available


  164. MAUGHAN-BROWN B, George G, Beckett S, Evans M, et al
    HIV Risk Among Adolescent Girls and Young Women in Age-Disparate Partnerships: Evidence From KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2018;78:155-162.
    PubMed     Text format     Abstract available



  165. Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome: Erratum.
    J Acquir Immune Defic Syndr. 2018;78:e13.
    PubMed     Text format    


  166. RADTKE KK, Bacchetti P, Anastos K, Merenstein D, et al
    Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2018;78:202-208.
    PubMed     Text format     Abstract available


    May 2018
  167. MAKI PM, Rubin LH, Springer G, Seaberg EC, et al
    Differences in Cognitive Function between Women and Men with HIV.
    J Acquir Immune Defic Syndr. 2018 May 25. doi: 10.1097/QAI.0000000000001764.
    PubMed     Text format     Abstract available


  168. SALESKA JL, Turner AN, Maierhofer C, Clark J, et al
    Use of antiretroviral therapy during pregnancy and adverse birth outcomes among women living with HIV-1 in low and middle-income countries: a systematic review.
    J Acquir Immune Defic Syndr. 2018 May 25. doi: 10.1097/QAI.0000000000001770.
    PubMed     Text format     Abstract available


  169. PORTER K, Gourlay A, Attawell K, Hales D, et al
    Substantial heterogeneity in progress towards reaching the 90-90-90 HIV target in the WHO European Region.
    J Acquir Immune Defic Syndr. 2018 May 25. doi: 10.1097/QAI.0000000000001761.
    PubMed     Text format     Abstract available


  170. KOETHE JR, Jenkins CA, Furch BD, Lake JE, et al
    Circulating Markers of Immunologic Activity Reflect Adiposity in Persons with HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 May 23. doi: 10.1097/QAI.0000000000001768.
    PubMed     Text format     Abstract available


  171. CHEN S, Wang X, Zhu H, Tang Q, et al
    Zidovudine-based treatments inhibit the glycosylation of ADAM17 and reduce CD163 shedding from monocytes.
    J Acquir Immune Defic Syndr. 2018 May 23. doi: 10.1097/QAI.0000000000001769.
    PubMed     Text format     Abstract available


  172. GOGIA S, Coromilas A, Regan S, Stone L, et al
    Cardiovascular Risk Profile of Transgender Women with HIV: A U.S. Healthcare Database Study.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001767.
    PubMed     Text format     Abstract available


  173. CALABRESE SK, Dovidio JF, Tekeste M, Taggart T, et al
    HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001762.
    PubMed     Text format     Abstract available


  174. STONER MC, Edwards JK, Miller WC, Aiello AE, et al
    Does partner selection mediate the relationship between school attendance and HIV/HSV-2 among adolescent girls and young women in South Africa: An analysis of HPTN 068 data.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001766.
    PubMed     Text format     Abstract available


  175. ORTBLAD KF, Musoke DK, Ngabirano T, Nakitende A, et al
    Female sex workers often incorrectly interpret HIV self-test results in Uganda.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001765.
    PubMed     Text format    


  176. ALPEREN J, Davidson J, Siminski S, Seage GR 3rd, et al
    The Utility of the National Death Index in Identifying Deaths in a Clinic-based, Multi-site Cohort: The Experience of the Pediatric HIV/AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001763.
    PubMed     Text format    


  177. D'ANTONI ML, Paul RH, Mitchell BI, Kohorn L, et al
    Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV Following Dual CCR2 and CCR5 Antagonism.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001752.
    PubMed     Text format     Abstract available


  178. SPRINGER SA, Di Paola A, Barbour R, Azar MM, et al
    Extended-release naltrexone improves viral suppression levels in prisoners with HIV and alcohol use disorders who are transitioning to the community: Results from a double-blind, placebo-controlled trial.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001759.
    PubMed     Text format     Abstract available


  179. NIELSEN SD, Ballegaard V, Pedersen KK, Pedersen M, et al
    Cytomegalovirus-Specific CD4+ T-cell Responses and CMV-IgG Levels are associated with Neurocognitive Impairment in People Living with HIV.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001753.
    PubMed     Text format     Abstract available


  180. LUOGA E, Vanobberghen F, Bircher R, Nyuri A, et al
    No HIV transmission from virally suppressed mothers during breastfeeding in rural Tanzania.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001758.
    PubMed     Text format     Abstract available


  181. RAMADHANI HO, Ndembi N, Nowak RG, Ononaku U, et al
    Individual and Network Factors Associated with HIV Care Continuum Outcomes Among Nigerian MSM Accessing HealthCare Services.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001756.
    PubMed     Text format     Abstract available


  182. NGUYEN AQ, Anjum SK, Halpern SE, Kumar K, et al
    Willingness to Donate Organs among People Living with HIV.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001760.
    PubMed     Text format     Abstract available


  183. RUBIN LH, Radtke KK, Eum S, Tamraz B, et al
    Cognitive burden of common non-antiretroviral medications in HIV-infected women.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001755.
    PubMed     Text format     Abstract available


  184. ANDREATTA K, Chang S, Martin R, Kulkarni R, et al
    HIV-1 Proviral Sequence And Treatment Outcome Of Virologically Suppressed Patients Switching To Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001757.
    PubMed     Text format    


  185. MUDINI W, Palefsky JM, Hale MJ, Chirenje MZ, et al
    Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV Seropositive and Seronegative Women in Zimbabwe.
    J Acquir Immune Defic Syndr. 2018 May 16. doi: 10.1097/QAI.0000000000001754.
    PubMed     Text format     Abstract available


  186. DYER TV, Khan MR, Regan R, Harawa NT, et al
    Differential Patterns of Risk and Vulnerability Suggest the Need for Novel Prevention Strategies for Black Bisexual Men in the HPTN 061 Study.
    J Acquir Immune Defic Syndr. 2018 May 10. doi: 10.1097/QAI.0000000000001716.
    PubMed     Text format     Abstract available


  187. GOLOVATY I, Sharma M, Van Heerden A, van Rooyen H, et al
    Cost of integrating non-communicable disease screening into home-based HIV testing and counseling in South Africa.
    J Acquir Immune Defic Syndr. 2018 May 10. doi: 10.1097/QAI.0000000000001713.
    PubMed     Text format     Abstract available


  188. BURGER EA, Dyer MA, Sy S, Palefsky JM, et al
    Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.
    J Acquir Immune Defic Syndr. 2018 May 9. doi: 10.1097/QAI.0000000000001727.
    PubMed     Text format     Abstract available


  189. BALAN IC, Frasca T, Dolezal C, Carballo-Dieguez A, et al
    HIV Risk Reduction by Avoiding Sex with Partners Unwilling to Undergo HIV Testing is Not Coercion.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001740.
    PubMed     Text format    


  190. MERLIN JS, Long D, Becker WC, Cachay ER, et al
    The Association of Chronic Pain and Long-Term Opioid Therapy with HIV Treatment Outcomes.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001741.
    PubMed     Text format     Abstract available


  191. LIGHTFOOT MA, Campbell CK, Moss N, Treves-Kagan S, et al
    Using a Social Network Strategy to Distribute HIV Self-Test Kits to African American and Latino MSM.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001726.
    PubMed     Text format     Abstract available


  192. CAHN P, Sax PE, Squires K, Molina JM, et al
    Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, non-inferiority trial.
    J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097/QAI.0000000000001723.
    PubMed     Text format     Abstract available


  193. ACHHRA AC, Sabin C, Ryom L, Hatleberg C, et al
    Body Mass Index and The Risk of Serious Non-Aids Events and All Cause Mortality in Treated Hiv-Positive Individuals: D: A: D Cohort Analysis.
    J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097/QAI.0000000000001722.
    PubMed     Text format     Abstract available


  194. MOREIRA RC, Mill JG, Grinsztejn B, Veloso V, et al
    HIV Infection Is Not Associated With Aortic Stiffness. Traditional Cardiovascular Risk Factors Are the Main Determinants-Cross-sectional Results of INI-ELSA-BRASIL.
    J Acquir Immune Defic Syndr. 2018;78:73-81.
    PubMed     Text format     Abstract available


  195. ARSHAD O, Gadawska I, Sattha B, Cote HCF, et al
    Elevated Cell-Free Mitochondrial DNA in Filtered Plasma Is Associated With HIV Infection and Inflammation.
    J Acquir Immune Defic Syndr. 2018;78:111-118.
    PubMed     Text format     Abstract available


  196. BEAULIEU T, Hayashi K, Milloy MJ, Nosova E, et al
    HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.
    J Acquir Immune Defic Syndr. 2018;78:93-98.
    PubMed     Text format     Abstract available


    April 2018
  197. GUITEAU MOISE C, Rivera VR, Hennessey KA, Bellot C, et al
    A Successful Model of Expedited Antiretroviral Therapy for Clinically Stable Patients Living with HIV in Haiti.
    J Acquir Immune Defic Syndr. 2018 Apr 30. doi: 10.1097/QAI.0000000000001725.
    PubMed     Text format     Abstract available


  198. WAKE RM, Jarvis JN, Harrison TS, Govender NP, et al
    Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immuno-Mycologics Lateral Flow Assay.
    J Acquir Immune Defic Syndr. 2018 Apr 30. doi: 10.1097/QAI.0000000000001721.
    PubMed     Text format     Abstract available


  199. LOPEZ-VARELA E, Fuente-Soro L, Augusto OJ, Sacoor C, et al
    The Continuum of HIV Care in Rural Mozambique: The Implications of HIV Testing Modality on Linkage and Retention.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001720.
    PubMed     Text format     Abstract available


  200. YANIK EL, Hernandez-Ramirez RU, Qin L, Lin H, et al
    Cutaneous Melanoma Risk among People with HIV in the United States and Canada.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001719.
    PubMed     Text format     Abstract available


  201. SHERMAN KE, Rouster SD, Kong LX, Shata TM, et al
    Zika Virus Exposure in an HIV-Infected Cohort in Ghana.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001718.
    PubMed     Text format     Abstract available


  202. VON BRAUN A, Sekaggya-Wiltshire C, Bachmann N, Ssemwanga D, et al
    HIV-1 drug resistance among Ugandan adults attending an urban out-patient clinic.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001717.
    PubMed     Text format     Abstract available


  203. NOVITSKY V, Gaolathe T, Mmalane M, Moyo S, et al
    Lack of Virological Suppression among Young HIV-Positive Adults in Botswana.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001715.
    PubMed     Text format     Abstract available


  204. SHIAU S, Strehlau R, Shen J, Violari A, et al
    Biomarkers of aging in HIV-infected children on suppressive antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001714.
    PubMed     Text format     Abstract available


  205. KATZ DA, Golden MR, Hughes JP, Farquhar C, et al
    HIV Self-Testing Increases HIV Testing Frequency in High Risk Men Who Have Sex with Men: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2018 Apr 24. doi: 10.1097/QAI.0000000000001709.
    PubMed     Text format     Abstract available


  206. MONROE AK, Myint L, Rutstein R, Aberg J, et al
    Factors Associated with Gaps in Medicaid Enrollment among People with HIV and the Effect of Gaps on Viral Suppression.
    J Acquir Immune Defic Syndr. 2018 Apr 24. doi: 10.1097/QAI.0000000000001702.
    PubMed     Text format     Abstract available


  207. LOGIE CH, Wang Y, Marcus NL, Levermore K, et al
    Pathways from sexual stigma to inconsistent condom use and condom breakage and slippage among men who have sex with men in Jamaica.
    J Acquir Immune Defic Syndr. 2018 Apr 24. doi: 10.1097/QAI.0000000000001712.
    PubMed     Text format     Abstract available


  208. SIFUNA P, Otieno L, Andagalu B, Oyieko J, et al
    A Spatial- Temporal Analysis of Hiv-Associated Mortality in Rural Western Kenya 2011-2015.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001710.
    PubMed     Text format     Abstract available


  209. KHURANA N, Yaylali E, Farnham PG, Hicks KA, et al
    Impact of Improved HIV Care and Treatment on PrEP Effectivenesss in the United States, 2016-2020.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001707.
    PubMed     Text format     Abstract available


  210. PERUMAL R, Abdelghani N, Naidu N, Yende-Zuma N, et al
    The risk of nephrotoxicity in patients with drug-resistant tuberculosis treated with kanamycin/capreomycin with or without concomitant use of tenofovir-containing antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001705.
    PubMed     Text format     Abstract available


  211. NORTH CM, Muyanja D, Kakuhikire B, Tsai AC, et al
    Systemic Inflammation, Immune Activation and Impaired Lung Function among People Living with HIV in Rural Uganda.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001711.
    PubMed     Text format     Abstract available


  212. AGOT K, Masters SH, Wango GN, Thirumurthy H, et al
    Can Women Safely Distribute HIV Oral Self-Test Kits to Their Sexual Partners? Results from a Pilot Study in Kenya.
    J Acquir Immune Defic Syndr. 2018 Apr 20. doi: 10.1097/QAI.0000000000001708.
    PubMed     Text format    


  213. MUIRU AN, Bibangambah P, Hemphill L, Sentongo R, et al
    Distribution and performance of cardiovascular risk scores in a mixed population of HIV-infected and community-based HIV-uninfected individuals in Uganda.
    J Acquir Immune Defic Syndr. 2018 Apr 11. doi: 10.1097/QAI.0000000000001696.
    PubMed     Text format     Abstract available


  214. GENBERG BL, Lee H, Hogan JW, Some F, et al
    Point of diagnosis and patient retention in HIV care in western Kenya.
    J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001703.
    PubMed     Text format     Abstract available


  215. PERDOMO-CELIS F, Taborda NA, Rugeles MT
    Circulating Cxcr5-Expressing Cd8+T-Cells are Major Producers of Il-21 and Associate with Limited Hiv Replication.
    J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001700.
    PubMed     Text format     Abstract available


  216. BEGLEY R, Das M, Zhong L, Ling J, et al
    Pharmacokinetics of Tenofovir Alafenamide When Co-administered With Other HIV Antiretrovirals.
    J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001699.
    PubMed     Text format     Abstract available


  217. PATEL VV, Dange A, Rawat S, Arnsten JH, et al
    Barriers to HIV testing among men who have sex with men in India reached online: implications for interventions.
    J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001698.
    PubMed     Text format    


  218. ONG JJ, Wei C, Pan S, Fu H, et al
    Individuals have the right to avoid sex with partners unwilling to test for HIV but do not have a right to force them to test for HIV.
    J Acquir Immune Defic Syndr. 2018 Apr 2. doi: 10.1097/QAI.0000000000001694.
    PubMed     Text format    


  219. FLASH CA, Adegboyega OO, Yu X, Avalos C, et al
    Correlates of Linkage to HIV Preexposure Prophylaxis Among HIV-Testing Clients.
    J Acquir Immune Defic Syndr. 2018;77:365-372.
    PubMed     Text format     Abstract available


    March 2018
  220. UNDERWOOD J, Cole JH, Leech R, Sharp DJ, et al
    Multivariate pattern analysis of volumetric neuroimaging data and its relationship with cognitive function in treated HIV-disease.
    J Acquir Immune Defic Syndr. 2018 Mar 30. doi: 10.1097/QAI.0000000000001687.
    PubMed     Text format     Abstract available


  221. READ T, Walker S, Chow E, Ong JJ, et al
    Hiv Testing with and without a Clinical Consultation Among Men who have Sex with Men: A Randomised Controlled Trial.
    J Acquir Immune Defic Syndr. 2018 Mar 29. doi: 10.1097/QAI.0000000000001688.
    PubMed     Text format     Abstract available


  222. ARNBJERG CJ, Vestad B, Hov JR, Pedersen KK, et al
    Effect of Lactobacillus Rhamnosus GG Supplementation on Intestinal Inflammation Assessed by Pet/Mri Scans and Gut Microbiota Composition in Hiv-Infected Individuals.
    J Acquir Immune Defic Syndr. 2018 Mar 29. doi: 10.1097/QAI.0000000000001693.
    PubMed     Text format     Abstract available


  223. FOLDYNA B, Fourman LT, Lu MT, Mueller ME, et al
    Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals with HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 Mar 27. doi: 10.1097/QAI.0000000000001686.
    PubMed     Text format     Abstract available


  224. CANAN CE, Chander G, Monroe AK, Gebo KA, et al
    High-Risk Prescription Opioid use Among People Living with Hiv.
    J Acquir Immune Defic Syndr. 2018 Mar 27. doi: 10.1097/QAI.0000000000001690.
    PubMed     Text format     Abstract available


  225. WAGNER AD, Shah SK, Njuguna IN, Porter KM, et al
    Letter to the Editor: Financial incentives to motivate pediatric HIV testing - assessing the potential for coercion, inducement, and voluntariness.
    J Acquir Immune Defic Syndr. 2018 Mar 27. doi: 10.1097/QAI.0000000000001689.
    PubMed     Text format    


  226. RIVERO-JUAREZ A, Camacho A, Brieva T, Frias M, et al
    Differential timing of cholesterol increase during successful HCV therapy: impact of type of drug combination.
    J Acquir Immune Defic Syndr. 2018 Mar 27. doi: 10.1097/QAI.0000000000001691.
    PubMed     Text format     Abstract available


  227. HUCK DM, Hanna DB, Rubin LH, Maki P, et al
    Carotid Artery Stiffness And Cognitive Decline Among Women With Or At Risk For Hiv Infection.
    J Acquir Immune Defic Syndr. 2018 Mar 23. doi: 10.1097/QAI.0000000000001685.
    PubMed     Text format     Abstract available


  228. MEIRELES MV, Pascom ARP, Duarte EC
    Factors associated with early virological response in HIV-infected individuals starting antiretroviral therapy in Brazil (2014-2015): results from a large HIV surveillance cohort.
    J Acquir Immune Defic Syndr. 2018 Mar 19. doi: 10.1097/QAI.0000000000001684.
    PubMed     Text format     Abstract available


  229. SHAVA E, Lipira LE, Beauchamp GG, Donnell DJ, et al
    Risky Sexual Behavior among Individuals receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058.
    J Acquir Immune Defic Syndr. 2018 Mar 19. doi: 10.1097/QAI.0000000000001683.
    PubMed     Text format     Abstract available


  230. TORRES-RUEDA S, Wambura M, Weiss HA, Plotkin M, et al
    Cost and Cost-Effectiveness of a Demand Creation Intervention to Increase Uptake of Voluntary Medical Male Circumcision in Tanzania: Spending More to Spend Less.
    J Acquir Immune Defic Syndr. 2018 Mar 19. doi: 10.1097/QAI.0000000000001682.
    PubMed     Text format     Abstract available


  231. DEMIR M, Phiri S, Heger E, Heller T, et al
    Prevalence of anti-HBs without anti-HBc among HIV-infected adults initiating antiretroviral therapy in Lilongwe, Malawi.
    J Acquir Immune Defic Syndr. 2018 Mar 13. doi: 10.1097/QAI.0000000000001681.
    PubMed     Text format    


  232. BERNAL E, Gomez JM, Jarrin I, Cano A, et al
    Low level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment.
    J Acquir Immune Defic Syndr. 2018 Mar 13. doi: 10.1097/QAI.0000000000001678.
    PubMed     Text format     Abstract available


  233. WILSON KS, Wanje G, Masese L, Simoni J, et al
    A prospective cohort study of fertility desire, unprotected sex, and detectable viral load in HIV-positive female sex workers in Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2018 Mar 13. doi: 10.1097/QAI.0000000000001680.
    PubMed     Text format     Abstract available


  234. KELESIDIS T, Moser CB, Johnston E, Stein JH, et al
    Changes in plasma RANKL-osteoprotegerin in a Prospective, Randomized Clinical trial of Initial Antiviral Therapy: A5260s.
    J Acquir Immune Defic Syndr. 2018 Mar 12. doi: 10.1097/QAI.0000000000001679.
    PubMed     Text format     Abstract available


  235. AHONKHAI AA, Banigbe B, Adeola J, Bassett IV, et al
    High Medication Possession Ratios Associated with Greater Risk of Virologic Failure Among Youth Compared to Adults in a Nigerian Cohort.
    J Acquir Immune Defic Syndr. 2018 Mar 9. doi: 10.1097/QAI.0000000000001670.
    PubMed     Text format     Abstract available


  236. EKE AC, Chakhtoura N, Kashuba A, Best BM, et al
    Rilpivirine Plasma and Cervico-Vaginal Concentrations in Women During Pregnancy and Postpartum.
    J Acquir Immune Defic Syndr. 2018 Mar 8. doi: 10.1097/QAI.0000000000001677.
    PubMed     Text format     Abstract available


  237. MORI M, Wichukchinda N, Miyahara R, Rojanawiwat A, et al
    The Impact of Hla Allele-Kir Pairs on Disease Outcome in Hiv-Infected Thai Population.
    J Acquir Immune Defic Syndr. 2018 Mar 8. doi: 10.1097/QAI.0000000000001676.
    PubMed     Text format     Abstract available


  238. CHENINE AL, Merbah M, Wieczorek L, Molnar S, et al
    Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones.
    J Acquir Immune Defic Syndr. 2018 Mar 8. doi: 10.1097/QAI.0000000000001675.
    PubMed     Text format     Abstract available


  239. RAO D, Kemp CG, Huh D, Nevin PE, et al
    Stigma Reduction Among African American Women with HIV: UNITY Health Study.
    J Acquir Immune Defic Syndr. 2018 Mar 8. doi: 10.1097/QAI.0000000000001673.
    PubMed     Text format     Abstract available


  240. WOOLS-KALOUSTIAN K, Marete I, Ayaya S, Sohn AH, et al
    Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort.
    J Acquir Immune Defic Syndr. 2018 Mar 2. doi: 10.1097/QAI.0000000000001667.
    PubMed     Text format     Abstract available


  241. PATHELA P, Jamison K, Braunstein SL, Schillinger JA, et al
    Gaps along the HIV care continuum: findings among a population seeking sexual health care services in New York City.
    J Acquir Immune Defic Syndr. 2018 Mar 2. doi: 10.1097/QAI.0000000000001674.
    PubMed     Text format     Abstract available


  242. NALINTYA E, Meya DB, Lofgren S, Hullsiek KH, et al
    A Prospective Evaluation of a multisite Cryptococcal Screening and Treatment program in HIV clinics in Uganda.
    J Acquir Immune Defic Syndr. 2018 Mar 2. doi: 10.1097/QAI.0000000000001669.
    PubMed     Text format     Abstract available


  243. SPITTAL PM, Malamba SS, Ogwang MD, Musisi S, et al
    Cango Lyec (Healing the Elephant): Gender differences in HIV infection in post-conflict Northern Uganda.
    J Acquir Immune Defic Syndr. 2018 Mar 2. doi: 10.1097/QAI.0000000000001671.
    PubMed     Text format     Abstract available


    February 2018
  244. STANOEVA KR, Konig A, Fukuda A, Kawanami Y, et al
    Total HIV-1 DNA dynamics and influencing factors in long-term ART-treated Japanese adults: a retrospective longitudinal analysis.
    J Acquir Immune Defic Syndr. 2018 Feb 23. doi: 10.1097/QAI.0000000000001662.
    PubMed     Text format     Abstract available


  245. QUERCIA R, Perno CF, Koteff J, Moore K, et al
    Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2018 Feb 22. doi: 10.1097/QAI.0000000000001660.
    PubMed     Text format     Abstract available


  246. LY W, Cocohoba J, Chyorny A, Halpern J, et al
    Perspectives on Integrated Hiv and Hcv Testing Among Persons Entering A Northern California Jail: A Pilot Study.
    J Acquir Immune Defic Syndr. 2018 Feb 22. doi: 10.1097/QAI.0000000000001664.
    PubMed     Text format     Abstract available


  247. DE ALMEIDA SM, Tang B, Ribeiro CE, Rotta I, et al
    Neprilysin in the cerebrospinal fluid and serum of patients infected with HIV1- subtypes C and B.
    J Acquir Immune Defic Syndr. 2018 Feb 21. doi: 10.1097/QAI.0000000000001666.
    PubMed     Text format     Abstract available


  248. ZUCKER J, Carnevale C, Rai AJ, Gordon P, et al
    Positive or Not, that is the Question: HIV Testing for Individuals on Pre-Exposure Prophylaxis (PrEP).
    J Acquir Immune Defic Syndr. 2018 Feb 21. doi: 10.1097/QAI.0000000000001665.
    PubMed     Text format    


  249. HODDER S, Squires K, Kityo C, Hagins D, et al
    Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/Taf) in Virologically Suppressed Women.
    J Acquir Immune Defic Syndr. 2018 Feb 21. doi: 10.1097/QAI.0000000000001663.
    PubMed     Text format     Abstract available


  250. BOGART LM, Mosepele M, Phaladze N, Lekoko B, et al
    A Social Network Analysis of HIV Treatment Partners and Patient Viral Suppression in Botswana.
    J Acquir Immune Defic Syndr. 2018 Feb 20. doi: 10.1097/QAI.0000000000001661.
    PubMed     Text format     Abstract available


  251. WARURU A, Achia TNO, Tobias JL, Ng'ang'a J, et al
    Finding Hidden Hiv Clusters to Support Geographic-Oriented Hiv Interventions in Kenya.
    J Acquir Immune Defic Syndr. 2018 Feb 16. doi: 10.1097/QAI.0000000000001652.
    PubMed     Text format     Abstract available


  252. HERMANSTYNE KA, Green HD Jr, Cook R, Tieu HV, et al
    Social Network Support and Decreased Risk of Seroconversion in Black MSM: Results of the Brothers (HPTN 061) Study.
    J Acquir Immune Defic Syndr. 2018 Feb 7. doi: 10.1097/QAI.0000000000001645.
    PubMed     Text format     Abstract available


  253. JI H, Patterson A, Taylor T, Rank C, et al
    Prevalence of primary drug resistance against HIV-1 Integrase Inhibitors in Canada.
    J Acquir Immune Defic Syndr. 2018 Feb 7. doi: 10.1097/QAI.0000000000001649.
    PubMed     Text format    


  254. KINYANDA E, Levin J, Nakasujja N, Birabwa H, et al
    Major depressive disorder: Longitudinal analysis of impact on clinical and behavioural outcomes in Uganda.
    J Acquir Immune Defic Syndr. 2018 Feb 7. doi: 10.1097/QAI.0000000000001647.
    PubMed     Text format     Abstract available


  255. TUMARKIN E, Heendeniya A, Murphy P, Placido T, et al
    HIV Post-Exposure Prophylaxis-in-Pocket ("PIP") for individuals with low frequency, high risk, HIV exposures.
    J Acquir Immune Defic Syndr. 2018 Feb 6. doi: 10.1097/QAI.0000000000001639.
    PubMed     Text format     Abstract available


  256. DEFILIPPI C, Christenson R, Joyce J, Park EA, et al
    Statin Effects on Myocardial Fibrosis Markers in People Living with HIV.
    J Acquir Immune Defic Syndr. 2018 Feb 6. doi: 10.1097/QAI.0000000000001644.
    PubMed     Text format     Abstract available


  257. ELION RA, Althoff KN, Zhang J, Moore RD, et al
    Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV.
    J Acquir Immune Defic Syndr. 2018 Feb 6. doi: 10.1097/QAI.0000000000001642.
    PubMed     Text format     Abstract available


  258. FULCHER JA, Shoptaw S, Makgoeng SB, Elliott J, et al
    Recent Methamphetamine Use is Associated with Increased Rectal Mucosal Inflammatory Cytokines Regardless of HIV-1 Serostatus.
    J Acquir Immune Defic Syndr. 2018 Feb 6. doi: 10.1097/QAI.0000000000001643.
    PubMed     Text format     Abstract available


  259. GOYETTE MS, Mutiti PM, Bukusi D, MMEd, et al
    Hiv Assisted Partner Services Among Those with and Without A History of Intimate Partner Violence in Kenya.
    J Acquir Immune Defic Syndr. 2018 Feb 5. doi: 10.1097/QAI.0000000000001638.
    PubMed     Text format     Abstract available


  260. FLORIDIA M, Pinnetti C, Ravizza M, Masuelli G, et al
    Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women with Hiv: Laboratory and Clinical Outcomes in an Observational National Study.
    J Acquir Immune Defic Syndr. 2018 Feb 5. doi: 10.1097/QAI.0000000000001640.
    PubMed     Text format     Abstract available


  261. KALICHMAN SC, Cherry C, Kalichman MO, Eaton LA, et al
    Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).
    J Acquir Immune Defic Syndr. 2018 Feb 5. doi: 10.1097/QAI.0000000000001637.
    PubMed     Text format     Abstract available


  262. NGONGONDO M, Miyahara S, Hughes MD, Sun X, et al
    Hepatotoxicity during Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living with HIV with Severe Immunosuppression: a Secondary Analysis of a Multi-country Open-label Randomized Controlled Clinical Trial.
    J Acquir Immune Defic Syndr. 2018 Feb 5. doi: 10.1097/QAI.0000000000001641.
    PubMed     Text format     Abstract available


    January 2018
  263. SMITH MK, Graham M, Latkin CA, Go VL, et al
    Using Contact Patterns to Inform HIV Interventions in Persons Who Inject Drugs in Northern Vietnam.
    J Acquir Immune Defic Syndr. 2018 Jan 30. doi: 10.1097/QAI.0000000000001632.
    PubMed     Text format     Abstract available


  264. CROCKETT KB, Rice WS, Turan B
    Associations Between Multiple Forms of Discrimination and Tobacco Use Among People Living with Hiv: The Mediating Role of Avoidance Coping.
    J Acquir Immune Defic Syndr. 2018 Jan 23. doi: 10.1097/QAI.0000000000001636.
    PubMed     Text format     Abstract available


  265. SPRINGER SA, Di Paola A, Azar M, Barbour R, et al
    Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.
    J Acquir Immune Defic Syndr. 2018 Jan 23. doi: 10.1097/QAI.0000000000001634.
    PubMed     Text format     Abstract available


  266. WEBEL AR, Moore SM, Longenecker CT, Currie J, et al
    A Randomized Controlled Trial of the Systemchange Intervention on Behaviors Related to Cardiovascular Risk in Hiv+ Adults.
    J Acquir Immune Defic Syndr. 2018 Jan 23. doi: 10.1097/QAI.0000000000001635.
    PubMed     Text format     Abstract available


  267. RAWAT A, Uebel K, Moore D, Yassi A, et al
    Integrated Hiv-Care into Primary Care Clinics and the Influence on Diabetes and Hypertension Care: An Interrupted Time Series Analysis in Free State, South Africa Over Four Years.
    J Acquir Immune Defic Syndr. 2018 Jan 23. doi: 10.1097/QAI.0000000000001633.
    PubMed     Text format     Abstract available


  268. CASTILLO-MANCILLA JR, Morrow M, Boum Y, Byakwaga H, et al
    Higher Art Adherence is Associated with Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.
    J Acquir Immune Defic Syndr. 2018 Jan 16. doi: 10.1097/QAI.0000000000001629.
    PubMed     Text format     Abstract available


  269. BURNETT S, Mubiru N, Imani P, Mbonye MK, et al
    Synergistic Impact of Training Followed By on-Site Support on Hiv Clinical Practice: A Mixed Design Study in Uganda with Pre/Post and Cluster Randomized Trial Components.
    J Acquir Immune Defic Syndr. 2018 Jan 16. doi: 10.1097/QAI.0000000000001630.
    PubMed     Text format     Abstract available


  270. PARCZEWSKI M, Cielniak I, Kordek J, Aksak-Was B, et al
    Identifying pre-existing NS3 and NS5A resistance-associated variants and transmission chains in the Polish HIV/HCV genotype 1 epidemic: impact on prevention and treatment.
    J Acquir Immune Defic Syndr. 2018 Jan 15. doi: 10.1097/QAI.0000000000001628.
    PubMed     Text format     Abstract available


  271. FRIEDMAN MR, Sang JM, Bukowski LA, Matthews DD, et al
    Hiv Care Continuum Disparities Among Bisexual Black Men and the Mediating Effect of Psychosocial Co-Morbidities.
    J Acquir Immune Defic Syndr. 2018 Jan 15. doi: 10.1097/QAI.0000000000001631.
    PubMed     Text format     Abstract available


  272. O'BRYAN TA, Agan BK, Tracy RP, Freiberg MS, et al
    Racial Comparison of D-dimer Levels in U.S. Male Military Personnel Before and After HIV Infection and Viral Suppression.
    J Acquir Immune Defic Syndr. 2018 Jan 8. doi: 10.1097/QAI.0000000000001626.
    PubMed     Text format     Abstract available


  273. DE BENEDETTO I, Masetti M, Fabbiani M, Biasin M, et al
    Higher Levels of Peripheral Th17 T Cd4+ Cells are Associated With Immunological Non-Response in Hiv-Infected Patients Undereffective Art.
    J Acquir Immune Defic Syndr. 2018 Jan 8. doi: 10.1097/QAI.0000000000001627.
    PubMed     Text format    


  274. HAHN JA, Cheng DM, Emenyonu NI, Lloyd-Travaglini C, et al
    Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort.
    J Acquir Immune Defic Syndr. 2018 Jan 4. doi: 10.1097/QAI.0000000000001624.
    PubMed     Text format     Abstract available


  275. PAUL R, Apornpong T, Prasitsuebsai W, Puthanakit T, et al
    Cognition, emotional health, and immunological markers in children with long-term nonprogressive HIV.
    J Acquir Immune Defic Syndr. 2018 Jan 4. doi: 10.1097/QAI.0000000000001619.
    PubMed     Text format     Abstract available


  276. ARMSTRONG-HOUGH M, Ggita J, Ayakaka I, Dowdy D, et al
    "Give Me Some Time": Facilitators of and Barriers to Uptake of Home-based HIV Testing During Household Contact Investigation for Tuberculosis in Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2018 Jan 3. doi: 10.1097/QAI.0000000000001617.
    PubMed     Text format     Abstract available


    December 2017
  277. WITTNER M, Dunay GA, Kummer S, Bockhorn M, et al
    Cd32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of Hiv Patients and Healthy Controls Correlates with Immune Activation.
    J Acquir Immune Defic Syndr. 2017 Dec 28. doi: 10.1097/QAI.0000000000001622.
    PubMed     Text format     Abstract available


  278. PALUMBO PJ, Fogel JM, Hudelson SE, Wilson EA, et al
    Hiv Drug Resistance in Adults Receiving Early Versus Delayed Antiretroviral Therapy: Hptn 052.
    J Acquir Immune Defic Syndr. 2017 Dec 28. doi: 10.1097/QAI.0000000000001623.
    PubMed     Text format     Abstract available


  279. KNETTEL BA, Cichowitz C, Ngocho JS, Knippler ET, et al
    Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: A Systematic Review and Meta-Analysis of Studies in Africa.
    J Acquir Immune Defic Syndr. 2017 Dec 27. doi: 10.1097/QAI.0000000000001616.
    PubMed     Text format     Abstract available


  280. BENHAMMOU V, Tubiana R, Matheron S, Sellier P, et al
    Hbv or Hcv Coinfection in Hiv-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
    J Acquir Immune Defic Syndr. 2017 Dec 27. doi: 10.1097/QAI.0000000000001618.
    PubMed     Text format     Abstract available


  281. STEKLER JD, Mcmahan V, Ballinger L, Viquez L, et al
    HIV Pre-exposure Prophylaxis (PrEP) Prescribing Through Telehealth.
    J Acquir Immune Defic Syndr. 2017 Dec 26. doi: 10.1097/QAI.0000000000001621.
    PubMed     Text format    


  282. JANULIS P, Phillips G 2nd, Birkett M, Mustanski B, et al
    Sexual Networks of Racially Diverse Young Msm Differ in Racial Homophily But not Concurrency.
    J Acquir Immune Defic Syndr. 2017 Dec 26. doi: 10.1097/QAI.0000000000001620.
    PubMed     Text format     Abstract available


  283. WAGNER AD, O'malley G, Firdawsi O, Mugo C, et al
    Disclosure, consent, opportunity costs, and inaccurate risk assessment deter pediatric HIV testing: a mixed-methods study.
    J Acquir Immune Defic Syndr. 2017 Dec 22. doi: 10.1097/QAI.0000000000001614.
    PubMed     Text format     Abstract available


  284. DORWARD J, Yende-Zuma N, Samsunder N, Karim QA, et al
    Clinic-Based Evaluation of A Point-Of-Care Creatinine Assay to Screen for Renal Impairment Amongst Hiv-Positive Patients Receiving Tenofovir Disoproxil Fumarate.
    J Acquir Immune Defic Syndr. 2017 Dec 15. doi: 10.1097/QAI.0000000000001613.
    PubMed     Text format    


  285. PATEL MR, Foote C, Duwve J, Chapman E, et al
    Reduction of Injection-Related Risk Behaviors Following Emergency Implementation of A Syringe Services Program During an Hiv Outbreak.
    J Acquir Immune Defic Syndr. 2017 Dec 15. doi: 10.1097/QAI.0000000000001615.
    PubMed     Text format     Abstract available


  286. FLYNN PM, Taha TE, Cababasay M, Fowler MG, et al
    Prevention of Hiv-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in Hiv-1-Infected Women with High Cd4 Cell Count (Impaact Promise): A Ran
    J Acquir Immune Defic Syndr. 2017 Dec 11. doi: 10.1097/QAI.0000000000001612.
    PubMed     Text format     Abstract available


  287. MORGAN FREIMAN J, Jacobson KR, Muyindike WR, Robert Horsburgh C, et al
    Isoniazid Preventive Therapy for People with HIV who are Heavy Alcohol Drinkers in High TB/HIV Burden Countries: a Risk-Benefit Analysis.
    J Acquir Immune Defic Syndr. 2017 Dec 6. doi: 10.1097/QAI.0000000000001610.
    PubMed     Text format     Abstract available


  288. ROHR JK, Ive P, Horsburgh CR, Berhanu R, et al
    Assessing the association between changing NRTIs when initiating second-line ART and treatment outcomes.
    J Acquir Immune Defic Syndr. 2017 Dec 4. doi: 10.1097/QAI.0000000000001611.
    PubMed     Text format     Abstract available


  289. FRENCH AL, Martin JW, Evans CT, Peters M, et al
    Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
    J Acquir Immune Defic Syndr. 2017;76:438-444.
    PubMed     Text format     Abstract available


  290. PATTERSON S, Carter A, Nicholson V, Webster K, et al
    Condomless Sex Among Virally Suppressed Women With HIV With Regular HIV-Serodiscordant Sexual Partners in the Era of Treatment as Prevention.
    J Acquir Immune Defic Syndr. 2017;76:372-381.
    PubMed     Text format     Abstract available


  291. SHARP A, O'Hagan R, Honermann B, Millett G, et al
    Setting Targets for HIV: An Evaluation of Indicator Quality and Target Achievement in National Strategic Plans.
    J Acquir Immune Defic Syndr. 2017;76:348-355.
    PubMed     Text format     Abstract available


  292. MARKOWITZ M, Grossman H, Anderson PL, Grant R, et al
    Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2017;76:e104-e106.
    PubMed     Text format    


    November 2017
  293. URICK B, Fong Y, Okiira C, Nabukeera-Barungi N, et al
    Rapid Serological Tests Ineffectively Screen for Hiv Exposure in Hiv-Positive Infants.
    J Acquir Immune Defic Syndr. 2017 Nov 28. doi: 10.1097/QAI.0000000000001609.
    PubMed     Text format     Abstract available


  294. LATAILLADE M, Zhou N, Joshi SR, Lee S, et al
    Viral Drug Resistance through 48 Weeks, in a Phase 2b, Randomized, Controlled Trial of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir.
    J Acquir Immune Defic Syndr. 2017 Nov 28. doi: 10.1097/QAI.0000000000001602.
    PubMed     Text format     Abstract available


  295. WOOD D, Lancaster KE, Boily MC, Powers KA, et al
    Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently?
    J Acquir Immune Defic Syndr. 2017 Nov 28. doi: 10.1097/QAI.0000000000001603.
    PubMed     Text format     Abstract available


  296. GLESBY MJ, Hanna DB, Hoover DR, Shi Q, et al
    Abdominal Fat Depots and Subclinical Carotid Artery Atherosclerosis in Women with and without HIV Infection.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001606.
    PubMed     Text format     Abstract available


  297. VAN EPPS P, Maier M, Lund B, Howren MB, et al
    "Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-Exposure Prophylaxis (PrEP) to Prevent HIV Infection".
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001598.
    PubMed     Text format     Abstract available


  298. NEWCOMB ME, Moran K, Feinstein BA, Forscher E, et al
    Pre-Exposure Prophylaxis (PrEP) Use and Condomless Anal Sex: Evidence of Risk Compensation in a Cohort of Young Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001604.
    PubMed     Text format     Abstract available


  299. CALKINS KL, Lesko CR, Chander G, Moore RD, et al
    Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen among Virally Suppressed Individuals.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001607.
    PubMed     Text format     Abstract available


  300. FAMILIAR I, Collins SM, Sikorskii A, Ruisenor-Escudero H, et al
    Quality of caregiving is positively associated with neurodevelopment during the first year of life among HIV-exposed uninfected children in Uganda.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001599.
    PubMed     Text format     Abstract available


  301. FLASH CA, Adegboyega OO, Yu X, Avalos C, et al
    Correlates of Linkage to HIV Pre-exposure Prophylaxis (PrEP) among HIV Testing Clients.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001605.
    PubMed     Text format     Abstract available


  302. LAFLEUR J, Bress AP, Esker S, Knippenberg K, et al
    Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001608.
    PubMed     Text format     Abstract available


  303. LIPPMAN SA, Lane T, Rabede O, Gilmore H, et al
    High Acceptability and Increased HIV Testing Frequency Following Introduction of HIV Self-Testing and Network Distribution among South African MSM.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001601.
    PubMed     Text format     Abstract available


  304. SEIFERT SM, Castillo-Mancilla JR, Erlandson K, Morrow M, et al
    Adherence biomarker measurements in older and younger HIV-infected adults receiving tenofovir-based therapy.
    J Acquir Immune Defic Syndr. 2017 Nov 17. doi: 10.1097/QAI.0000000000001596.
    PubMed     Text format     Abstract available


  305. ISHMAEL LEJONE T, Ringera I, Cheleboi M, Wagner S, et al
    The treatment cascade in children with unsuppressed viral load - a reality check in rural Lesotho, Southern Africa.
    J Acquir Immune Defic Syndr. 2017 Nov 17. doi: 10.1097/QAI.0000000000001597.
    PubMed     Text format     Abstract available


  306. HERBECK JT, Kerani RP, Poon AFY
    What Proportion of Hiv-Infected Foreign-Born Individuals in The U.S. Have Been Infected After Immigrating to The U.S.?
    J Acquir Immune Defic Syndr. 2017 Nov 15. doi: 10.1097/QAI.0000000000001594.
    PubMed     Text format    


  307. FARHADIAN S, Jalbert E, Deng Y, Goetz MB, et al
    HIV and Age Do Not Synergistically Affect Age-Related T cell Markers.
    J Acquir Immune Defic Syndr. 2017 Nov 13. doi: 10.1097/QAI.0000000000001595.
    PubMed     Text format     Abstract available


  308. KAY ES, Rice WS, Crockett KB, Atkins GC, et al
    Experienced Hiv-Related Stigma in Healthcare and Community Settings: Mediated Associations With Psychosocial and Health Outcomes.
    J Acquir Immune Defic Syndr. 2017 Nov 13. doi: 10.1097/QAI.0000000000001590.
    PubMed     Text format     Abstract available


  309. GOLUB SA, Lelutiu-Weinberger C, Surace A
    An Experimental Investigation of Implicit Hiv And Prep Stigma: Evidence For Ancillary Benefits of Prep Use.
    J Acquir Immune Defic Syndr. 2017 Nov 13. doi: 10.1097/QAI.0000000000001592.
    PubMed     Text format     Abstract available


  310. MMBAGA EJ, Moen K, Leyna GH, Mpembeni R, et al
    Hiv Prevalence and Associated Risk Factors Among Men Who Have Sex With Men in Dar Es Salaam, Tanzania.
    J Acquir Immune Defic Syndr. 2017 Nov 13. doi: 10.1097/QAI.0000000000001593.
    PubMed     Text format     Abstract available


  311. ERLANDSON KM, Lake JE, Sim M, Falutz J, et al
    Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared to Men.
    J Acquir Immune Defic Syndr. 2017 Nov 11. doi: 10.1097/QAI.0000000000001591.
    PubMed     Text format     Abstract available


  312. MORGAN E, Skaathun B, Duvoisin R, Michaels S, et al
    Are Hiv Seroconversions Among Young Men Who Have Sex With Men Associated With Social Network Proximity To Recently Or Long-Term Hiv-Infected Individuals?
    J Acquir Immune Defic Syndr. 2017 Nov 8. doi: 10.1097/QAI.0000000000001586.
    PubMed     Text format     Abstract available


  313. LOGIE CH, Lacombe-Duncan A, Wang Y, Kaida A, et al
    Pathways from Hiv-Related Stigma to Antiretroviral Therapy Measures in The Hiv Care Cascade for Women Living with Hiv in Canada.
    J Acquir Immune Defic Syndr. 2017 Nov 8. doi: 10.1097/QAI.0000000000001589.
    PubMed     Text format     Abstract available


  314. ROBINSON JA, Marzinke MA, Fuchs EJ, Bakshi RP, et al
    Comparison Of The Pharmacokinetics And Pharmacodynamics Of Single-Dose Tenofovir Vaginal Film And Gel Formulation (Fame-05).
    J Acquir Immune Defic Syndr. 2017 Nov 7. doi: 10.1097/QAI.0000000000001587.
    PubMed     Text format     Abstract available


  315. MUGWANYA KK, Baeten JM, Wyatt C, Mugo NR, et al
    Frequency of monitoring kidney function in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Nov 6. doi: 10.1097/QAI.0000000000001575.
    PubMed     Text format     Abstract available


  316. NAKIWALA JK, Walker NF, Diedrich CR, Worodria W, et al
    Neutrophil activation and enhanced release of granule products in HIV-TB immune reconstitution inflammatory syndrome.
    J Acquir Immune Defic Syndr. 2017 Nov 6. doi: 10.1097/QAI.0000000000001582.
    PubMed     Text format     Abstract available


  317. STEVENS ER, Nucifora K, Zhou Q, Braithwaite RS, et al
    Cost-Effectiveness Of Peer- Versus Venue-Based Approaches For Detecting Undiagnosed Hiv Among Heterosexuals In High-Risk New York City Neighborhoods.
    J Acquir Immune Defic Syndr. 2017 Nov 6. doi: 10.1097/QAI.0000000000001578.
    PubMed     Text format     Abstract available


  318. GUNARATNAM P, McManus H, Watchirs-Smith L, McGregor S, et al
    People Born In Non-Main English Speaking Countries Are Less Likely To Start Hiv Treatment Early In Australia: A National Cohort Analysis, 2014-15.
    J Acquir Immune Defic Syndr. 2017 Nov 6. doi: 10.1097/QAI.0000000000001585.
    PubMed     Text format    


  319. ONG JJ, Li H, Dan W, Fu H, et al
    Coercion And Hiv Self-Testing In Men Who Have Sex With Men: Implementation Data From A Cross-Sectional Survey In China.
    J Acquir Immune Defic Syndr. 2017 Nov 2. doi: 10.1097/QAI.0000000000001583.
    PubMed     Text format    


  320. SKAATHUN B, Khanna AS, Morgan E, Friedman SR, et al
    Network Viral Load: A Critical Metric For Hiv Elimination.
    J Acquir Immune Defic Syndr. 2017 Nov 2. doi: 10.1097/QAI.0000000000001584.
    PubMed     Text format     Abstract available


  321. EYAWO O, McGinnis KA, Justice AC, Fiellin DA, et al
    Alcohol and Mortality: Combining Self-reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected.
    J Acquir Immune Defic Syndr. 2017 Nov 2. doi: 10.1097/QAI.0000000000001588.
    PubMed     Text format     Abstract available


  322. LAVERICK R, Haddow L, Daskalopoulou M, Lampe F, et al
    Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV.
    J Acquir Immune Defic Syndr. 2017;76:e74-e83.
    PubMed     Text format     Abstract available


  323. HAWKINS C, Christian B, Fabian E, Macha I, et al
    Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults.
    J Acquir Immune Defic Syndr. 2017;76:298-302.
    PubMed     Text format     Abstract available


    October 2017
  324. BRITES C, Abrahao M, Bozza P, Netto EM, et al
    Infection By Htlv-1 Is Associated With High Levels Of Pro-Inflammatory Cytokines, In Hiv-Hcv Coinfected Patients.
    J Acquir Immune Defic Syndr. 2017 Oct 27. doi: 10.1097/QAI.0000000000001576.
    PubMed     Text format     Abstract available


  325. FELLER DJ, Zucker J, Yin MT, Gordon P, et al
    Using Clinical Notes and Natural Language Processing for Automated HIV Risk Assessment.
    J Acquir Immune Defic Syndr. 2017 Oct 27. doi: 10.1097/QAI.0000000000001580.
    PubMed     Text format     Abstract available


  326. MAZANDERANI AH, Moyo F, Kufa T, Sherman GG, et al
    Declining Baseline Viraemia and Escalating Discordant HIV-1 Confirmatory Results within South Africa's Early Infant Diagnosis Program, 2010-2016.
    J Acquir Immune Defic Syndr. 2017 Oct 27. doi: 10.1097/QAI.0000000000001581.
    PubMed     Text format     Abstract available


  327. MAYER KH, Chan PA, Patel R, Flash CA, et al
    Evolving models and ongoing challenges for HIV pre-exposure prophylaxis implementation in the United States.
    J Acquir Immune Defic Syndr. 2017 Oct 27. doi: 10.1097/QAI.0000000000001579.
    PubMed     Text format     Abstract available


  328. CABRAL A, Baeten J, Ngure K, Velloza J, et al
    Intimate partner violence and self-reported pre-exposure prophylaxis (PrEP) interruptions among HIV-negative partners in HIV serodiscordant couples in Kenya and Uganda.
    J Acquir Immune Defic Syndr. 2017 Oct 23. doi: 10.1097/QAI.0000000000001574.
    PubMed     Text format     Abstract available


  329. NESHEIM SR, Linley L, Gray KM, Zhang T, et al
    Country of birth of children with diagnosed HIV infection in the United States, 2008-2014.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001572.
    PubMed     Text format     Abstract available


  330. HADDOW L, Laverick R, Leung I, Post F, et al
    Measurement of retinal vessels as a biomarker of cerebrovascular ageing in older HIV positive men compared to controls.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001570.
    PubMed     Text format     Abstract available


  331. KIDMAN R, Violari A
    Dating violence against HIV-infected youth in South Africa: Associations with sexual risk behavior, medication adherence, and mental health.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001569.
    PubMed     Text format     Abstract available


  332. VOJDEMAN FJ, Gaardbo JC, Hartling HJ, Gelpi M, et al
    CD52 expression on CD4+ T cells in HIV-positive individuals on cART.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001568.
    PubMed     Text format     Abstract available


  333. KOETHE JR, McDonnell W, Kennedy A, Abana CO, et al
    Adipose Tissue is Enriched for Activated and Late-differentiated CD8+ T cells, and Shows Distinct CD8+ Receptor Usage, Compared to Blood in HIV-infected Persons.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001573.
    PubMed     Text format     Abstract available


  334. TRAISATHIT P, Delory T, Ngo-Giang-Huong N, Somsamai R, et al
    AIDS-defining events and deaths in HIV-infected children and adolescents on antiretrovirals: a 14-year study in Thailand.
    J Acquir Immune Defic Syndr. 2017 Oct 14. doi: 10.1097/QAI.0000000000001571.
    PubMed     Text format     Abstract available


  335. VAN DEN BERG JJ, Javanbakht M, Gorbach PM, Rudy BJ, et al
    Partner Notification for Youth Living with HIV in 14 Cities in the United States.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001565.
    PubMed     Text format     Abstract available


  336. COWGER T, Thai LH, Duong BD, Danyuttapolchai J, et al
    Programmatic Evaluation of an Algorithm for Intensified TB Case Finding and Isoniazid Preventive Therapy for People Living with HIV in Thailand and Vietnam.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001551.
    PubMed     Text format     Abstract available


  337. CANIGLIA EC, Phillips A, Porter K, Sabin CA, et al
    Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001562.
    PubMed     Text format     Abstract available


  338. TANG EC, Vittinghoff E, Anderson PL, Cohen SE, et al
    Changes in Kidney Function Associated with Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001566.
    PubMed     Text format     Abstract available


  339. NESHEIM SR, Wiener J, Fitz Harris LF, Lampe MA, et al
    Estimated incidence of perinatally acquired HIV infection in the United States, 1978-2013.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001552.
    PubMed     Text format     Abstract available


  340. PRICE JT, Rosenberg NE, Vansia D, Phanga T, et al
    Predictors of HIV, HIV Risk Perception, and HIV Worry among Adolescent Girls and Young Women in Lilongwe, Malawi.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001567.
    PubMed     Text format     Abstract available


  341. LALLY MA, van den Berg JJ, Westfall AO, Rudy BJ, et al
    HIV Continuum of Care for Youth in the United States.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001563.
    PubMed     Text format     Abstract available


  342. HART BB, Nordell AD, Okulicz JF, Palfreeman A, et al
    Inflammation Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001554.
    PubMed     Text format     Abstract available


  343. CARD KG, Armstrong HL, Lachowsky NJ, Cui Z, et al
    Belief in Treatment As Prevention and Its Relationship to HIV Status and Behavioral Risk.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001557.
    PubMed     Text format     Abstract available


  344. MUSARANDEGA R, Mutede B, Mahomva A, Nyamayaro W, et al
    Scaling up pediatric HIV testing by incorporating provider-initiated HIV testing into all child health services in Hurungwe District, Zimbabwe.
    J Acquir Immune Defic Syndr. 2017 Oct 4. doi: 10.1097/QAI.0000000000001564.
    PubMed     Text format     Abstract available



  345. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery: Erratum.
    J Acquir Immune Defic Syndr. 2017;76:e64.
    PubMed     Text format    


  346. WILTON J, Mishra S, Tan DHS
    Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP.
    J Acquir Immune Defic Syndr. 2017;76:e58-e61.
    PubMed     Text format    


  347. SANDFORT TGM, Knox JR, Alcala C, El-Bassel N, et al
    Substance Use and HIV Risk Among Men Who Have Sex With Men in Africa: A Systematic Review.
    J Acquir Immune Defic Syndr. 2017;76:e34-e46.
    PubMed     Text format     Abstract available


  348. ONDIEK J, Namukaya Z, Mtapuri-Zinyowera S, Balkan S, et al
    Multicountry Validation of SAMBA - A Novel Molecular Point-of-Care Test for HIV-1 Detection in Resource-Limited Setting.
    J Acquir Immune Defic Syndr. 2017;76:e52-e57.
    PubMed     Text format     Abstract available


  349. FABBIANI M, Muscatello A, Perseghin P, Bani M, et al
    Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated With the Evolution of Cognitive Performance in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2017;76:219-224.
    PubMed     Text format     Abstract available


  350. SMOLDERS EJ, Smit C, T M M de Kanter C, Dofferiiof ASM, et al
    Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.
    J Acquir Immune Defic Syndr. 2017;76:193-199.
    PubMed     Text format     Abstract available


  351. MISRA K, Udeagu CC
    Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015-2017.
    J Acquir Immune Defic Syndr. 2017;76:132-140.
    PubMed     Text format     Abstract available


    September 2017
  352. BOCK P, Jennings K, Vermaak R, Cox H, et al
    Incidence of Tuberculosis amongst HIV positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa.
    J Acquir Immune Defic Syndr. 2017 Sep 29. doi: 10.1097/QAI.0000000000001560.
    PubMed     Text format     Abstract available


  353. PYRA M, Haberer JE, Heffron R, Kidoguchi L, et al
    PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.
    J Acquir Immune Defic Syndr. 2017 Sep 29. doi: 10.1097/QAI.0000000000001561.
    PubMed     Text format     Abstract available


  354. CATTANEO D, Minisci D, Baldelli S, Mazzali C, et al
    Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001558.
    PubMed     Text format     Abstract available


  355. ANZINGER JJ, Butterfield TR, Gouillou M, McCune JM, et al
    Glut1 Expression Level on Inflammatory Monocytes is Associated with Markers of Cardiovascular Disease Risk in HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001559.
    PubMed     Text format    


  356. INZAULE SC, Osi SJ, Akinbiyi G, Emeka A, et al
    High prevalence of HIV drug resistance among newly diagnosed infants aged <18 months: results from a nationwide surveillance in Nigeria.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001553.
    PubMed     Text format     Abstract available


  357. LEVASSEUR MT, Goldstein ND, Tabb LP, Olivieri-Mui BL, et al
    The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001555.
    PubMed     Text format     Abstract available


  358. DORWARD J, Mabuto T, Charalambous S, Fielding KL, et al
    Factors associated with poor linkage to HIV care in South Africa: secondary analysis of data from the Thol'impilo trial.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001550.
    PubMed     Text format     Abstract available


  359. BALKUS JE, Brown ER, Palanee-Phillips T, Kiweewa FM, et al
    Performance of a validated risk score to predict HIV-1 acquisition among African women participating in a trial of the dapivirine vaginal ring.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001556.
    PubMed     Text format    


  360. HABERER JE, Ngure K, Muwonge T, Mugo N, et al
    Context matters: PrEP adherence is associated with sexual behavior among HIV serodiscordant couples in East Africa.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001548.
    PubMed     Text format     Abstract available


  361. SHUPER PA, Joharchi N, Monti PM, Loutfy M, et al
    Acute Alcohol Consumption Directly Increases HIV Transmission Risk: A Randomized Controlled Experiment.
    J Acquir Immune Defic Syndr. 2017 Sep 18. doi: 10.1097/QAI.0000000000001549.
    PubMed     Text format     Abstract available


  362. FERRETTI F, Mora-Peris B, Underwood J, Waldman A, et al
    Cognitive Impairment in a Clinical Setting.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001547.
    PubMed     Text format    


  363. ECKARD AR, O'Riordan MA, Rosebush JC, Ruff JH, et al
    Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-infected Youth.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001545.
    PubMed     Text format     Abstract available


  364. ZHANG HL, Rhea SK, Hurt CB, Mobley VL, et al
    HIV pre-exposure prophylaxis implementation at local health departments: a statewide assessment of activities and barriers.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001546.
    PubMed     Text format     Abstract available


  365. STONER MCD, Edwards JK, Miller WC, Aiello AE, et al
    The effect of schooling on age-disparate relationships and number of sexual partners among young women in rural South Africa enrolled in HPTN 068.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001544.
    PubMed     Text format     Abstract available


  366. LANDOVITZ RJ, Beymer M, Kofron R, Amico KR, et al
    Plasma Tenofovir-levels to Support Adherence to TDF/FTC Pre-exposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001538.
    PubMed     Text format     Abstract available


  367. FIRNHABER C, Swarts A, Goeieman B, Rakhombe N, et al
    Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001539.
    PubMed     Text format     Abstract available


  368. VALVERDE EE, Oster AM, Xu S, Wertheim JO, et al
    HIV Transmission Dynamics among Foreign-born Persons in the United States.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001541.
    PubMed     Text format     Abstract available


  369. PLOTZKER R, Seekaew P, Jantarapakde J, Pengnonyang S, et al
    The Importance of Risk Perception: Predictors of PrEP Acceptance Among Thai MSM and TG Women at a Community-Based Health Service.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001536.
    PubMed     Text format     Abstract available


  370. GREBE E, Welte A, Hall J, Keating SM, et al
    Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001537.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: